{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:38:39Z","timestamp":1792795119562,"version":"4.5.0"},"reference-count":462,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1097\/md.0b013e3182954af1","type":"journal-article","created":{"date-parts":[[2013,5,3]],"date-time":"2013-05-03T13:12:46Z","timestamp":1367586766000},"page":"135-181","source":"Crossref","is-referenced-by-count":189,"title":["Causes of Death and Prognostic Factors in Multiple Endocrine Neoplasia Type 1"],"prefix":"10.1097","volume":"92","author":[{"given":"Tetsuhide","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisato","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.","family":"Berna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210226","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1067\/mob.2001.108856","article-title":"Ovarian gastrinoma in multiple endocrine neoplasia type I: a case report.","volume":"184","author":"Abboud","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"R2-3-20210226","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2176\/nmc.33.309","article-title":"Cerebral aneurysm associated with multiple endocrine neoplasia, type 1case report.","volume":"33","author":"Adachi","year":"1993","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"R3-3-20210226","first-page":"117","article-title":"Acute renal failure as an initial manifestation of multiple endocrine neoplasia (MEN) type 1.","volume":"23","author":"Afshar","year":"2012","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R4-3-20210226","first-page":"251","article-title":"A case of pathologic autopsy of type 1 endocrine adenomatosis (MEN) which combined hypophyseal adenoma, thyroid adenoma, parathyroid adenoma, gastric carcinod, glucagonoma and adrenal cortical adenoma.","volume":"45","author":"Akimoto","year":"1997","journal-title":"Horumon To Rinsho"},{"key":"R5-3-20210226","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1365-2559.2005.02202.x","article-title":"Heterotropic cardiac calcification: a rare presentation of multiple endocrine neoplasia.","volume":"47","author":"Al-Daraji","year":"2005","journal-title":"Histopathology"},{"key":"R6-3-20210226","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF03346599","article-title":"Intracranial ependymoma associated with multiple endocrine neoplasia type 1.","volume":"33","author":"Al-Salameh","year":"2010","journal-title":"J Endocrinol Invest"},{"key":"R7-3-20210226","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00000658-199808000-00013","article-title":"Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.","volume":"228","author":"Alexander","year":"1998","journal-title":"Ann Surg"},{"key":"R8-3-20210226","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4158\/EP.14.5.595","article-title":"Diagnosis by serendipity: Cushing syndrome attributable to cortisol-producing adrenal adenoma as the initial manifestation of multiple endocrine neoplasia type 1 due to a rare splicing site MEN1 gene mutation.","volume":"14","author":"Alzahrani","year":"2008","journal-title":"Endocr Pract"},{"key":"R9-3-20210226","first-page":"5440","article-title":"Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features.","volume":"12","author":"Anlauf","year":"2006","journal-title":"World J"},{"key":"R10-3-20210226","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/gut.2006.108910","article-title":"Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions.","volume":"56","author":"Anlauf","year":"2007","journal-title":"Gut"},{"key":"R11-3-20210226","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1067\/msy.2002.128607","article-title":"Long-term results of less than total parathyroidectomy for hyperparathyroidism in multiple endocrine neoplasia type 1.","volume":"132","author":"Arnalsteen","year":"2002","journal-title":"Surgery"},{"key":"R12-3-20210226","first-page":"1123","article-title":"Apparent lymph node primary gastrinoma.","volume":"116","author":"Arnold","year":"1994","journal-title":"Surgery"},{"key":"R13-3-20210226","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1158\/1078-0432.CCR-0938-3","article-title":"Meningiomas may be a component tumor of MEN1.","volume":"10","author":"Asgharian","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R14-3-20210226","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1210\/jc.2004-0218","article-title":"Cutaneous tumors in patients with MEN1 and gastrinomas: Prospective study of frequency and development of criteria with high sensitivity and specificity.","volume":"89","author":"Asgharian","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-3-20210226","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00005792-196407000-00003","article-title":"Familial endocrine adenoma-peptic ulcer complex.","volume":"43","author":"Ballard","year":"1964","journal-title":"Medicine (Baltimore)"},{"key":"R16-3-20210226","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.tem.2006.09.004","article-title":"Menin and its interacting proteins: elucidation of menin function.","volume":"17","author":"Balogh","year":"2006","journal-title":"Trends Endocrinol Metab"},{"key":"R17-3-20210226","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00508-007-0884-2","article-title":"Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors.","volume":"119","author":"Banasch","year":"2007","journal-title":"Wien Klin Wochenschr"},{"key":"R18-3-20210226","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.dld.2011.09.014","article-title":"Magnetic resonance imaging versus endoscopic ultrasonography for the detection of pancreatic tumours in multiple endocrine neoplasia type 1.","volume":"44","author":"Barbe","year":"2012","journal-title":"Dig Liver Dis"},{"key":"R19-3-20210226","first-page":"1420","article-title":"Progastrin in serum from Zollinger-Ellison patients.","volume":"98","author":"Bardram","year":"1990","journal-title":"An indicator of malignancy Gastroenterology"},{"key":"R20-3-20210226","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0016-5085(86)80014-2","article-title":"Bone metastases in malignant gastrinoma.","volume":"91","author":"Barton","year":"1986","journal-title":"Gastroenterology"},{"key":"R21-3-20210226","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.sla.0000189549.51913.d8","article-title":"Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1.","volume":"242","author":"Bartsch","year":"2005","journal-title":"Ann Surg"},{"key":"R22-3-20210226","first-page":"958","article-title":"Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance Surgery.","volume":"128","author":"Bartsch","year":"2000","journal-title":""},{"key":"R23-3-20210226","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0022-5347(05)66068-5","article-title":"Multiple endocrine neoplasia type 1 and adrenal lesions.","volume":"166","author":"Barzon","year":"2001","journal-title":"J Urol"},{"key":"R24-3-20210226","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1046\/j.1365-2036.2002.01249.x","article-title":"Prospective study of the ability of histamine, serotonin or chromogranin A levels to identify gastric carcinoids in patients with gastrinomas.","volume":"16","author":"Bashir","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"R25-3-20210226","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1055\/s-0028-1105167","article-title":"Das Wermer-syndrome: hereditare endokrine polyadenomatose.","volume":"93","author":"Becker","year":"1968","journal-title":"Deutsche Medizinsche Wochen"},{"key":"R26-3-20210226","first-page":"1498","article-title":"Variable regions of chromosome 11 loss in different pathological tissues of a patient with the multiple endocrine neoplasia type 1 syndrome.","volume":"79","author":"Beckers","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-3-20210226","first-page":"564","article-title":"Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locus.","volume":"75","author":"Beckers","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"R28-3-20210226","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4158\/EP.4.3.153","article-title":"Malignant thymic carcinoid in multiple endocrine neoplasia type I syndrome: case report and literature review.","volume":"4","author":"Bekele","year":"1998","journal-title":"Endocr Pract"},{"key":"R29-3-20210226","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0002-9343(87)90008-8","article-title":"Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type I.","volume":"82","author":"Benson","year":"1987","journal-title":"Am J Med"},{"key":"R30-3-20210226","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.0954-6820.1985.tb01657.x","article-title":"Effects of secretin on parathyroid hormone and calcium in normal subjects, patients with hyperparathyroidism and patients with gastrinoma.","volume":"217","author":"Benson","year":"1985","journal-title":"Acta Med Scand"},{"key":"R31-3-20210226","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0002-9343(94)90323-9","article-title":"Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type 1.","volume":"97","author":"Benya","year":"1994","journal-title":"Am J Med"},{"key":"R32-3-20210226","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000224142","article-title":"Pluriglandular syndrome.","volume":"15","author":"Berdjis","year":"1962","journal-title":"Oncologia"},{"key":"R33-3-20210226","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1200\/JCO.2001.19.12.3051","article-title":"Prognostic value of initial fasting serum gastrin level in patients with Zollinger-Ellison syndrome.","volume":"19","author":"Berger","year":"2001","journal-title":"J Clin Oncol"},{"key":"R34-3-20210226","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1210\/jc.2007-2279","article-title":"A prospective study of gastric carcinoids and enterochromaffin-like cells changes in multple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.","volume":"93","author":"Berna","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R35-3-20210226","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/MD.0b013e31802b518c","article-title":"Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. Evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features.","volume":"85","author":"Berna","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"R36-3-20210226","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.md.0000236956.74128.76","article-title":"Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature.","volume":"85","author":"Berna","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"R37-3-20210226","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/annonc\/mdm552","article-title":"Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours.","volume":"19","author":"Bettini","year":"2008","journal-title":"Ann Oncol"},{"key":"R38-3-20210226","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2265.2002.01535.x","article-title":"Ectopic growth hormone-releasing hormone secretion by thymic carcioid tumour.","volume":"57","author":"Boix","year":"2002","journal-title":"Clin Endocrinol"},{"key":"R39-3-20210226","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1523-1747.1998.00317.x","article-title":"Somatic mutations of the MEN1 tumor suppressor gene detected in sporadic angiofibromas.","volume":"111","author":"Boni","year":"2003","journal-title":"J Invest Dermatol"},{"key":"R40-3-20210226","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/00000478-199709000-00012","article-title":"Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I.","volume":"21","author":"Bordi","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"R41-3-20210226","first-page":"257","article-title":"Management of nonfunctioning pancreatic endocrine tumors in the context of multiple endocrine neoplasia type 1 syndrome.","volume":"16","author":"Botsios","year":"2007","journal-title":"J Gastrointestin Liver Dis"},{"key":"R42-3-20210226","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2.","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R43-3-20210226","first-page":"829","article-title":"Syndrome de Zollinger-Ellison associe a une tumeur de la loge hypophysaire. Interet pratique de la recherche du pouvoir secretagogue urinaire.","volume":"117","author":"Bricaire","year":"1966","journal-title":"Societe Medicale des Hopitaux de Paris"},{"key":"R44-3-20210226","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/archsurg.133.2.126","article-title":"The outcome of subtotal parathyroidectomy for the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1.","volume":"133","author":"Burgess","year":"1998","journal-title":"Arch Surg"},{"key":"R45-3-20210226","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1046\/j.1365-2265.2001.01348.x","article-title":"Malignant thymic carcinoid is not prevented by transcervical thymectomy in multiple endocrine neoplasia type 1.","volume":"55","author":"Burgess","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R46-3-20210226","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<428::AID-CNCR10>3.0.CO;2-Y","article-title":"Enteropancreatic malignancy associated with multiple endocrine neoplasia type 1.","volume":"83","author":"Burgess","year":"1998","journal-title":"Cancer"},{"key":"R47-3-20210226","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2796.1998.00275.x","article-title":"Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1.","volume":"243","author":"Burgess","year":"1998","journal-title":"J Intern Med"},{"key":"R48-3-20210226","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/archsurg.1996.01430190021006","article-title":"Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1.","volume":"131","author":"Burgess","year":"1996","journal-title":"Arch Surg"},{"key":"R49-3-20210226","first-page":"2642","article-title":"Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN1): clinical, biochemical, and radiological features of pituitary disease in a large MEN1 kindred.","volume":"81","author":"Burgess","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R50-3-20210226","first-page":"105","article-title":"Multiple endocrine neoplasia type 1 (MEN1) as a cancer predisposition syndrome: clues into the mechanisms of MEN1-related carcinogenesis.","volume":"79","author":"Busygina","year":"2006","journal-title":"Yale J Biol Med"},{"key":"R51-3-20210226","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00595-008-3763-1","article-title":"Cervical metastases of glucagonoma in a patient with multiple endocrine neoplasia type 1: report of a case.","volume":"38","author":"Butte","year":"2008","journal-title":"Surg Today"},{"key":"R52-3-20210226","first-page":"1018","article-title":"Stenosing esophagitis in Zollinger-Ellison syndrome.","volume":"18","author":"Cadiot","year":"1994","journal-title":"Gastroenterol Clin Biol"},{"key":"R53-3-20210226","first-page":"579","article-title":"Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome Gastroenterology.","volume":"105","author":"Cadiot","year":"1993","journal-title":""},{"key":"R54-3-20210226","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0016-5085(99)70124-1","article-title":"Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1.","volume":"116","author":"Cadiot","year":"1999","journal-title":"Gastroenterology"},{"key":"R55-3-20210226","first-page":"44","article-title":"Zollinger-Ellison syndrome; clinical features and long-term follow-up.","volume":"49","author":"Cameron","year":"1974","journal-title":"Mayo Clin Proc"},{"key":"R56-3-20210226","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/BF03350301","article-title":"Pulmonary lymphangioleiomyoma in a patient with multiple endocrine neoplasia type I.","volume":"20","author":"Carnevale","year":"1997","journal-title":"J Endocrinol Invest"},{"key":"R57-3-20210226","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1067\/msy.1998.93107","article-title":"The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1.","volume":"124","author":"Carty","year":"1998","journal-title":"Surgery"},{"key":"R58-3-20210226","first-page":"1024","article-title":"Prospective study of aggressive resection of metastatic pancreatic endocrine tumors.","volume":"112","author":"Carty","year":"1992","journal-title":"Surgery"},{"key":"R59-3-20210226","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2265.2002.01505.x","article-title":"Mutational analysis of Portuguese families with multiple endocrine neoplasia type 1 reveals large germline deletions.","volume":"56","author":"Cavaco","year":"2002","journal-title":"Clin Endocrinol"},{"key":"R60-3-20210226","first-page":"131","article-title":"Zollinger-Ellison syndrome and parathyroid adenoma. Limits of Wermers syndrome.","volume":"112","author":"Champault","year":"1976","journal-title":"J Chir (Paris)"},{"key":"R61-3-20210226","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11864-011-0148-2","article-title":"New treatment options for patients with advanced neuroendocrine tumors.","volume":"12","author":"Chan","year":"2011","journal-title":"Curr Treat Options Oncol"},{"key":"R62-3-20210226","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1.","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"key":"R63-3-20210226","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000185466","article-title":"Management of patients and subjects at risk for multiple endocrine neoplasia type 1: MEN1.","volume":"47","author":"Chanson","year":"1997","journal-title":"Horm Res"},{"key":"R64-3-20210226","doi-asserted-by":"crossref","first-page":"841","DOI":"10.7326\/0003-4819-105-6-841","article-title":"Selective venous sampling for gastrin to localize gastrinomas. A prospective study.","volume":"105","author":"Cherner","year":"1986","journal-title":"Ann Intern Med"},{"key":"R65-3-20210226","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1053\/meta.2000.17708","article-title":"Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level.","volume":"49","author":"Chiu","year":"2000","journal-title":"Metabolism"},{"key":"R66-3-20210226","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3349\/ymj.2008.49.4.655","article-title":"Multiple endocrine neoplasia type 1 with multiple leiomyomas linked to a novel mutation in the MEN1 gene.","volume":"49","author":"Choi","year":"2008","journal-title":"Yonsei Med J"},{"key":"R67-3-20210226","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/BF02557521","article-title":"Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas.","volume":"9","author":"Chu","year":"2002","journal-title":"Ann Surg Oncol"},{"key":"R68-3-20210226","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0002-9343(59)90238-4","article-title":"Parathyroid and pancreatic adenomas.","volume":"26","author":"Cohen","year":"1959","journal-title":"Am J Med"},{"key":"R69-3-20210226","doi-asserted-by":"crossref","first-page":"52","DOI":"10.7326\/0003-4819-100-1-52","article-title":"Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion.","volume":"100","author":"Collen","year":"1984","journal-title":"Ann Intern Med"},{"key":"R70-3-20210226","first-page":"215","article-title":"Changing patterns in presentation and management of the Zollinger-Ellison syndrome in Northern Ireland, 1970-1988.","volume":"78","author":"Collins","year":"1991","journal-title":"Q J Med"},{"key":"R71-3-20210226","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0001-4001(00)00112-4","article-title":"Insulinomas in multiple endocrine neoplasia type 1. Report of a series of 44 cases by the multiple endocrine neoplasia study group.","volume":"125","author":"Cougard","year":"2000","journal-title":"Ann Chir"},{"key":"R72-3-20210226","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/archinte.1972.00320040043003","article-title":"Familial multiple endocrine adenomatosis: multiple endocrine neoplasia, type I.","volume":"129","author":"Craven","year":"1972","journal-title":"Arch Intern Med"},{"key":"R74-3-20210226","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archderm.1997.03890430067009","article-title":"Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1.","volume":"133","author":"Darling","year":"1997","journal-title":"Arch Dermatol"},{"key":"R75-3-20210226","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000326164","article-title":"Presentation and outcome of pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1 syndrome.","volume":"94","author":"Davi","year":"2011","journal-title":"Neuroendocrinology"},{"key":"R76-3-20210226","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2265.2011.04145.x","article-title":"New therapeutic options for metastatic malignant insulinomas.","volume":"75","author":"de Herder","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R77-3-20210226","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/030089160108700411","article-title":"Type B1 thymoma in multiple endocrine neoplasia type 1 (MEN-1) syndrome.","volume":"87","author":"De Toma","year":"2001","journal-title":"Tumori"},{"key":"R78-3-20210226","first-page":"1437","article-title":"Are patients with multiple endocrine neoplasia type I prone to premature death World J Surg.","volume":"24","author":"Dean","year":"2000","journal-title":""},{"key":"R79-3-20210226","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0016-5085(97)70171-9","article-title":"The multiple endocrine neoplasia type 1 gene locus is involved in the pathogenesis of type II gastric carcinoids.","volume":"113","author":"Debelenko","year":"1997","journal-title":"Gastroenterology"},{"key":"R80-3-20210226","first-page":"2238","article-title":"Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type-I-associated sporadic gastrinomas and pancreatic endocrine tumors.","volume":"57","author":"Debelenko","year":"1997","journal-title":"Cancer Res"},{"key":"R81-3-20210226","first-page":"212","article-title":"Insulinoma in a patient with MEN 1 syndrome9-year follow-up: case report.","volume":"61","author":"Debski","year":"2010","journal-title":"Endokrynol Pol"},{"key":"R82-3-20210226","first-page":"998","article-title":"Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach.","volume":"110","author":"Demeure","year":"1991","journal-title":"Surgery"},{"key":"R83-3-20210226","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0015-0282(16)37267-3","article-title":"Zollinger-Ellison syndrome in a patient with secondary amenorrhea; report of a case with fatal outcome.","volume":"21","author":"DeNeef","year":"1970","journal-title":"Fertil Steril"},{"key":"R84-3-20210226","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0022-5347(17)45120-2","article-title":"Hypernephroma associated with multiple endocrine neoplasia type I: a case report.","volume":"136","author":"Denker","year":"1986","journal-title":"J Urol"},{"key":"R85-3-20210226","doi-asserted-by":"crossref","first-page":"680","DOI":"10.7326\/0003-4819-87-6-680","article-title":"Use of calcium and secretin in the diagnosis of gastrinoma (Zollinger-Ellison syndrome).","volume":"87","author":"Deveney","year":"1977","journal-title":"Ann Intern Med"},{"key":"R86-3-20210226","doi-asserted-by":"crossref","first-page":"866","DOI":"10.4065\/77.8.866","article-title":"Concurrent parathyroid adenomas and carcinoma in the setting of multiple endocrine neoplasia type 1: presentation as hypercalcemic crisis.","volume":"77","author":"Dionisi","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"R87-3-20210226","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0960-7404(03)00038-0","article-title":"Multiple endocrine neoplasia type 1: duodenopancreatic tumors.","volume":"12","author":"Doherty","year":"2003","journal-title":"Surg Oncol"},{"key":"R88-3-20210226","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s002689900438","article-title":"Lethality of multiple endocrine neoplasia type I.","volume":"22","author":"Doherty","year":"1998","journal-title":"World J Surg"},{"key":"R89-3-20210226","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1210\/jcem.82.5.3944","article-title":"Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1.","volume":"82","author":"Dong","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R90-3-20210226","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/1097-0142(19910915)68:6<1329::AID-CNCR2820680624>3.0.CO;2-7","article-title":"Surgical pathology of gastrinoma: site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy.","volume":"68","author":"Donow","year":"1991","journal-title":"Cancer"},{"key":"R91-3-20210226","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1148\/radiology.174.1.2294556","article-title":"Gastrinomas: localization by means of selective intraarterial injection of secretin.","volume":"174","author":"Doppman","year":"1990","journal-title":"Radiology"},{"key":"R92-3-20210226","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1148\/radiology.178.1.1984311","article-title":"Insulinomas: localization with selective intraarterial injection of calcium.","volume":"178","author":"Doppman","year":"1991","journal-title":"Radiology"},{"key":"R93-3-20210226","first-page":"173","article-title":"Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine types I and IIa: is a more or less extended operation essential Eur J Surg.","volume":"167","author":"Dotzenrath","year":"2001","journal-title":""},{"key":"R94-3-20210226","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1067\/msy.2001.109500","article-title":"Malignant endocrine tumors in patients with MEN1 disease.","volume":"129","author":"Dotzenrath","year":"2001","journal-title":"Surgery"},{"key":"R95-3-20210226","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/acta.0.1000189","article-title":"Pituitary prolactinoma, adrenal aldosterone-producing adenomas, gastric schwannoma and colonic polyadenomas: a possible variant of multiple endocrine neoplasia (MEN) type I.","volume":"100","author":"Doumith","year":"1982","journal-title":"Acta Endocrinol (Copenh)"},{"key":"R96-3-20210226","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1172\/JCI108636","article-title":"Gastric emptying and secretion in Zollinger-Ellison syndrome.","volume":"59","author":"Dubois","year":"1977","journal-title":"J Clin Invest"},{"key":"R97-3-20210226","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/ajcp\/82.4.481","article-title":"Mixed type Zollinger-Ellison syndrome in a florid case of multiple endocrine neoplasia type I.","volume":"82","author":"Duggan","year":"1984","journal-title":"Am J Clin Pathol"},{"key":"R98-3-20210226","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0002-9610(87)90305-9","article-title":"Carcinoids associated with multiple endocrine neoplasia syndromes.","volume":"154","author":"Duh","year":"1987","journal-title":"Am J Surg"},{"key":"R99-3-20210226","first-page":"1293","article-title":"Renal oncocytoma in multiple endocrine neoplasia type 1.","volume":"21","author":"Duquenne","year":"1992","journal-title":"Presse Med"},{"key":"R100-3-20210226","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1677\/ERC-08-0301","article-title":"Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma.","volume":"16","author":"Durante","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"R101-3-20210226","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1210\/jc.2003-031513","article-title":"Effect of multiple endocrine neoplasia type 1 (MEN1) gene mutations on premature mortality in familial MEN1 syndrome with founder mutations.","volume":"89","author":"Ebeling","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R102-3-20210226","first-page":"76","article-title":"Multiple endocrine neoplasia, type I (MEN I).","volume":"46","author":"Eberle","year":"1981","journal-title":"Ergeb Inn Med Kinderheilkd"},{"key":"R103-3-20210226","doi-asserted-by":"crossref","first-page":"7798","DOI":"10.1158\/1078-0432.CCR-08-0734","article-title":"Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution.","volume":"14","author":"Ekeblad","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R104-3-20210226","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0039-6060(03)00406-9","article-title":"Results of initial operation for hyperparathryoidism (HPT) in patients with multiple endocrine neoplasia type 1 (MEN1).","volume":"134","author":"Elaraj","year":"2003","journal-title":"Surgery"},{"key":"R105-3-20210226","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00000658-199522240-00009","article-title":"Forty-year appraisal of gastrinoma.","volume":"222","author":"Ellison","year":"1995","journal-title":"Ann Surg"},{"key":"R106-3-20210226","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0002-9343(87)90423-2","article-title":"Early surgical treatment of gastrinoma.","volume":"82","author":"Ellison","year":"1987","journal-title":"Am J Med"},{"key":"R107-3-20210226","first-page":"147","article-title":"The ulcerogenic tumors of the pancreas.","volume":"40","author":"Ellison","year":"1956","journal-title":"Surgery"},{"key":"R108-3-20210226","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/00000658-196409000-00013","article-title":"The Zollinger-Ellison syndrome: re-appraisal and evaluation of 260 registered cases.","volume":"160","author":"Ellison","year":"1964","journal-title":"Ann Surg"},{"key":"R109-3-20210226","first-page":"92","article-title":"An autopsy case of a MEN1 patient complicating mucinous carcinoma of the colon with neurendocrine differentiation.","volume":"77","author":"Emi","year":"2001","journal-title":"Nihon Naibunpi Gakkai Zasshi"},{"key":"R110-3-20210226","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000335587","article-title":"ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.","volume":"95","author":"Falconi","year":"2012","journal-title":"Neuroendocrinology"},{"key":"R111-3-20210226","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1210\/jc.2004-1155","article-title":"Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series.","volume":"90","author":"Ferolla","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R112-3-20210226","first-page":"293","article-title":"Hypergastrinemia. Physiopathological and clinical aspects with a study of a series of Zollinger-Ellison cases.","volume":"45","author":"Fiasse","year":"1982","journal-title":"Acta Gastroenterol Belg"},{"key":"R113-3-20210226","first-page":"279","article-title":"Use of octreotide in the treatment of digestive neuroendocrine tumours. Seven year experience in 20 cases including 9 cases of metastatic midgut carcinoid and 5 cases of metastatic gastrinoma.","volume":"56","author":"Fiasse","year":"1993","journal-title":"Acta Gastroenterol Belg"},{"key":"R114-3-20210226","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/bjs.6051","article-title":"Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas.","volume":"95","author":"Fischer","year":"2008","journal-title":"Br J Surg"},{"key":"R115-3-20210226","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7326\/0003-4819-119-3-199308010-00004","article-title":"Assessment and prediction of long-term cure in patients with Zollinger-Ellison syndrome: the best approach.","volume":"119","author":"Fishbeyn","year":"1993","journal-title":"Ann Intern Med"},{"key":"R116-3-20210226","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2337\/diacare.28.7.1769","article-title":"Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence.","volume":"28","author":"Ford","year":"2005","journal-title":"Diabetes Care"},{"key":"R117-3-20210226","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/00000658-197410000-00020","article-title":"The influence of total gastrectomy on survival in malignant Zollinger-Ellison tumors.","volume":"180","author":"Fox","year":"1974","journal-title":"Ann Surg"},{"key":"R118-3-20210226","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00000658-199409000-00008","article-title":"Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma.","volume":"220","author":"Fraker","year":"1994","journal-title":"Ann Surg"},{"key":"R119-3-20210226","first-page":"994","article-title":"Chronic hypoglycemia.","volume":"27","author":"Friedman","year":"1939","journal-title":"Arch Pathol"},{"key":"R120-3-20210226","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/BF01654811","article-title":"The development of endocrinopathies in the prospective screening of two families with multiple endocrine adenopathy, type I.","volume":"3","author":"Friesen","year":"1979","journal-title":"World J Surg"},{"key":"R121-3-20210226","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1148\/radiology.171.3.2655004","article-title":"Gastrinomas: comparison of MR imaging with CT, angiography and US.","volume":"171","author":"Frucht","year":"1989","journal-title":"Radiology"},{"key":"R122-3-20210226","doi-asserted-by":"crossref","first-page":"713","DOI":"10.7326\/0003-4819-111-9-713","article-title":"Secretin and calcium provocative tests in the Zollinger-Ellison syndrome: a prospective study.","volume":"111","author":"Frucht","year":"1989","journal-title":"Ann Intern Med"},{"key":"R123-3-20210226","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/BF01298865","article-title":"Use of omeprazole in patients with the Zollinger-Ellison syndrome.","volume":"36","author":"Frucht","year":"1991","journal-title":"Dig Dis Sci"},{"key":"R124-3-20210226","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/0016-5085(90)90466-E","article-title":"Detection of duodenal gastrinomas by operative endoscopic transillumination: a prospective study.","volume":"99","author":"Frucht","year":"1990","journal-title":"Gastroenterology"},{"key":"R125-3-20210226","first-page":"567","article-title":"A case report of glucagonoma with hepatic metastases in multiple endocrine neoplasia type 1.","volume":"78","author":"Fujio","year":"2001","journal-title":"Japanese J Clin Exp Med"},{"key":"R126-3-20210226","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1507\/endocrj.41.731","article-title":"Insulin sensitivity and glycemic control before and after parathyroidectomy in a diabetic patient with familial multiple endocrine neoplasia type 1.","volume":"41","author":"Furuto-Kato","year":"1994","journal-title":"Endocr J"},{"key":"R127-3-20210226","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.hoc.2007.04.003","article-title":"Liver-directed therapies for metastatic neuroendocrine tumors.","volume":"21","author":"Garrot","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"key":"R128-3-20210226","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/EJE-11-0679","article-title":"Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe detude des Tumeurs Endocrines database.","volume":"166","author":"Gatta-Cherifi","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"R129-3-20210226","first-page":"577","article-title":"Do patients with multiple endocrine neoplasia syndrome type 1 benefit from periodical screening Eur J Endocrinol.","volume":"149","author":"Geerdink","year":"2003","journal-title":""},{"key":"R130-3-20210226","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.4158\/EP11038.CR","article-title":"Cushing syndrome secondary to a thymic carcinoid tumor due to multiple endocrine neoplasia type 1.","volume":"17","author":"Ghazi","year":"2011","journal-title":"Endocr Pract"},{"key":"R131-3-20210226","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1210\/jc.2002-021314","article-title":"Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1.","volume":"88","author":"Gibril","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R132-3-20210226","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1148\/radiology.198.1.8539410","article-title":"Metastatic gastrinomas: localization with selective arterial injection of secretin.","volume":"198","author":"Gibril","year":"1996","journal-title":"Radiology"},{"key":"R133-3-20210226","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1200\/JCO.1998.16.3.1040","article-title":"Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and MRI in their detection, their frequency, location and effect of their detection on management.","volume":"16","author":"Gibril","year":"1998","journal-title":"J Clin Oncol"},{"key":"R134-3-20210226","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.dld.2003.11.024","article-title":"Diagnostic uses of radiolabelled somatostatin-receptor analogues in gastroenteropancreatic endocrine tumors.","volume":"36","author":"Gibril","year":"2004","journal-title":"Dig Liver Dis"},{"key":"R135-3-20210226","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s11894-004-0067-5","article-title":"Zollinger-Ellison syndrome revisited: diagnosis, biologic markers, associated inherited disorders, and acid hypersecretion.","volume":"6","author":"Gibril","year":"2004","journal-title":"Curr Gastroenterol Rep"},{"key":"R136-3-20210226","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11894-005-0049-2","article-title":"Advances in evaluation and management of gastrinoma in patients with Zollinger-Ellison syndrome.","volume":"7","author":"Gibril","year":"2005","journal-title":"Curr Gastroenterol Rep"},{"key":"R137-3-20210226","first-page":"539","article-title":"Specificity of somatostatin receptor scintigraphy: a prospective study and the effects of false positive localizations on management in patients with gastrinomas.","volume":"40","author":"Gibril","year":"1999","journal-title":"J Nucl Med"},{"key":"R138-3-20210226","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7326\/0003-4819-125-1-199607010-00005","article-title":"Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas: a prospective study.","volume":"125","author":"Gibril","year":"1996","journal-title":"Ann Intern Med"},{"key":"R139-3-20210226","first-page":"1646","article-title":"Ability of somatostatin receptor scintigraphy to identify patients with localized gastric carcinoids: a prospective study.","volume":"41","author":"Gibril","year":"2000","journal-title":"J Nucl Med"},{"key":"R140-3-20210226","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.md.0000112297.72510.32","article-title":"Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. A prospective study of 107 cases and comparison with 1009 patients from the literature.","volume":"83","author":"Gibril","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"R141-3-20210226","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1210\/jcem.86.11.8011","article-title":"Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form.","volume":"86","author":"Gibril","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R142-3-20210226","first-page":"3487","article-title":"A large multiple endocrine neoplasia type 1 family with clinical expression suggestive of anticipation.","volume":"82","author":"Giraud","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R143-3-20210226","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1086\/301953","article-title":"Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders.","volume":"63","author":"Giraud","year":"1998","journal-title":"Am J Hum Genet"},{"key":"R144-3-20210226","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/MPA.0b013e3182374e08","article-title":"Surgical management of insulinomas in multiple endocrine neoplasia type 1.","volume":"41","author":"Giudici","year":"2012","journal-title":"Pancreas"},{"key":"R145-3-20210226","first-page":"123","article-title":"Surgical strategies for treatment of malignant pancreatic tumors: extended, standard or local surgery World J Surg Oncol.","volume":"6","author":"Glanemann","year":"2008","journal-title":""},{"key":"R146-3-20210226","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1210\/jcem.85.1.6260","article-title":"Geneotypephenotype correlations of MEN1 gene mutations in sporadic gastrinoma.","volume":"85","author":"Goebel","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R147-3-20210226","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2265.2006.02697.x","article-title":"Metastatic prolactinoma presenting as a cervical spinal cord tumour in multiple endocrine neoplasia type one (MEN-1).","volume":"66","author":"Gordon","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R148-3-20210226","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/EJE-10-0950","article-title":", Verges B, Cardot-Bauters C. Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe detude des Tumeurs Endocrines.","volume":"165","author":"Goudet","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"R149-3-20210226","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00268-001-0046-z","article-title":"Hyperparathyroidism in multiple endocrine neoplasia type I: surgical trends and results of a 256-patient series from Groupe dEtude des Neoplasies Endocriniennes Multiples study group.","volume":"25","author":"Goudet","year":"2001","journal-title":"World J Surg"},{"key":"R150-3-20210226","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00268-009-0290-1","article-title":"Risk factors and causes of death in MEN1 disease. A GTE (Groupe dEtude des Tumeurs Endocrines) cohort study among 758 patients.","volume":"34","author":"Goudet","year":"2010","journal-title":"World J Surg"},{"key":"R151-3-20210226","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00268-009-9980-y","article-title":"Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines).","volume":"33","author":"Goudet","year":"2009","journal-title":"World J Surg"},{"key":"R152-3-20210226","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.anchir.2003.11.013","article-title":"Les gastrinomes dans les neoplasies endocriniennes multiples de type 1. Une etude de cohorte de 127 cas du groupe des tumeurs endocrines (GTE).","volume":"129","author":"Goudet","year":"2004","journal-title":"Ann Chir"},{"key":"R153-3-20210226","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/BF02067341","article-title":"Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes.","volume":"16","author":"Grama","year":"1992","journal-title":"World J Surg"},{"key":"R155-3-20210226","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1210\/jcem.84.8.5938","article-title":"Plasma chromogranin A in patients with multiple endocrine neoplasia type 1.","volume":"84","author":"Granberg","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R157-3-20210226","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1477-7819-9-6","article-title":"Bilateral adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1 (MEN1) and a novel mutation in the MEN1 gene.","volume":"9","author":"Griniatsos","year":"2011","journal-title":"World J Surg Oncol"},{"key":"R158-3-20210226","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0002-9610(66)90130-9","article-title":"Zollinger-Ellison syndrome with interesting variations.","volume":"112","author":"Guida","year":"1966","journal-title":"Am J Surg"},{"key":"R159-3-20210226","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1111\/j.1572-0241.2003.07704.x","article-title":"Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study.","volume":"98","author":"Gullo","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R160-3-20210226","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s12094-007-0121-5","article-title":"Glucagonoma with two pancreatic masses and pulmonary metastases as debut of MEN-1.","volume":"9","author":"Gutierrez","year":"2007","journal-title":"Clin Transl Oncol"},{"key":"R161-3-20210226","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12020-010-9424-3","article-title":"A new mutation in the menin gene causes the multiple endocrine neoplasia type 1 syndrome with adrenocortical carcinoma.","volume":"39","author":"Haase","year":"2011","journal-title":"Endocrine"},{"key":"R162-3-20210226","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.surg.2008.05.012","article-title":"Multimodal treatment of sporadic and inherited neuroendocrine tumors of the thymus.","volume":"144","author":"Habbe","year":"2008","journal-title":"Surgery"},{"key":"R163-3-20210226","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"R164-3-20210226","doi-asserted-by":"crossref","first-page":"154541","DOI":"10.4061\/2011\/154541","article-title":"Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review.","volume":"2011","author":"Harring","year":"2011","journal-title":"Int J Hepatol"},{"key":"R165-3-20210226","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/acta.0.1130189","article-title":"Multiple endocrine neoplasia with Cushings syndrome due to paraganglioma producing corticotropin-releasing factor and adrenocorticotropin.","volume":"113","author":"Hashimoto","year":"1986","journal-title":"Acta Endocrinol (Copenh)"},{"key":"R166-3-20210226","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.surg.2004.06.049","article-title":"The surgical management of MEN-1 pancreatoduodenal neuroendocrine disease.","volume":"136","author":"Hausman","year":"2004","journal-title":"Surgery"},{"key":"R167-3-20210226","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.pnpbp.2005.08.008","article-title":"Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion.","volume":"29","author":"Hebb","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R168-3-20210226","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/BF02067367","article-title":"Findings and long-term results of parathyroid surgery in multiple endocrine neoplasia type 1.","volume":"16","author":"Hellman","year":"1992","journal-title":"World J Surg"},{"key":"R169-3-20210226","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0039-6060(98)70040-6","article-title":"Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1.","volume":"124","author":"Hellman","year":"1998","journal-title":"Surgery"},{"key":"R170-3-20210226","first-page":"1355","article-title":"Multiple allelic deletions and intratumoral genetic heterogeneity in MEN1 pancreatic tumors.","volume":"86","author":"Hessman","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R171-3-20210226","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1046\/j.1365-2036.2001.01097.x","article-title":"Long-term lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors: a prospective 10-year study.","volume":"15","author":"Hirschowitz","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"R172-3-20210226","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1542-3565(04)00606-8","article-title":"Clinical outcome using lansoprazole in acid hypersecretors with and without Zollinger-Ellison syndrome: a 13-year prospective study.","volume":"3","author":"Hirschowitz","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R173-3-20210226","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1200\/JCO.2002.10.030","article-title":"Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups.","volume":"20","author":"Hochwald","year":"2002","journal-title":"J Clin Oncol"},{"key":"R174-3-20210226","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.bpg.2005.05.009","article-title":"Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment.","volume":"19","author":"Hoffmann","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R175-3-20210226","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1210\/jc.2005-1349","article-title":"Patients with multiple endocrine neoplasia type 1 with gastrinomas have an increased risk of severe esophageal disease including stricture and the premalignant condition, Barretts esophagus.","volume":"91","author":"Hoffmann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R176-3-20210226","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/BF03042664","article-title":"Multiple endocrine neoplasia associated with multiple lipomas.","volume":"93","author":"Hofmann","year":"1998","journal-title":"Med Klin"},{"key":"R177-3-20210226","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1440-1827.2010.02527.x","article-title":"Diagnostic approach to pancreatic tumors with the specimens of endoscopic ultrasound-guided fine needle aspiration.","volume":"60","author":"Hosoda","year":"2010","journal-title":"Pathol Int"},{"key":"R178-3-20210226","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0016-5085(85)80024-X","article-title":"Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome.","volume":"88","author":"Howard","year":"1985","journal-title":"Gastroenterology"},{"key":"R179-3-20210226","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/archsurg.141.3.235","article-title":"Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1.","volume":"141","author":"Hubbard","year":"2006","journal-title":"Arch Surg"},{"key":"R180-3-20210226","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/0002-9343(64)90069-5","article-title":"Peptic ulcer with islet cell tumor: a reappraisal.","volume":"37","author":"Huizenga","year":"1964","journal-title":"Am J Med"},{"key":"R181-3-20210226","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3748\/wjg.v17.i10.1343","article-title":"Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients.","volume":"17","author":"Imamura","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R183-3-20210226","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1507\/endocrj.K10E-158","article-title":"Attenuated expression of menin and p27 (Kip1) in an aggressive case of multiple endocrine neoplasia type 1 (MEN1) associated with an atypical prolactinoma and a malignant pancreatic endocrine tumor.","volume":"58","author":"Ishida","year":"2011","journal-title":"Endocr J"},{"key":"R184-3-20210226","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/(SICI)1097-0215(19970410)71:2<308::AID-IJC28>3.0.CO;2-B","article-title":"Processing-independent assay of serum gastrin for diagnosis of liver metastases in the Zollinger-Ellison syndrome. GRESZE (Groupe de Recherche et dEtude du syndrome de Zollinger-Ellison).","volume":"71","author":"Jais","year":"1997","journal-title":"Int J Cancer"},{"key":"R185-3-20210226","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2265.1998.3471213.x","article-title":"Acromegaly and Cushings syndrome due to ectopic production of GHRH and ACTH by a thymic carcinoid tumour: in vitro responses to GHRH and GHRP-6.","volume":"48","author":"Jansson","year":"1998","journal-title":"Clin Endocrinol"},{"key":"R186-3-20210226","first-page":"103","article-title":"Wermer syndrome associated with a bilateral renal tumor.","volume":"6","author":"Jeddi","year":"1996","journal-title":"Prog Urol"},{"key":"R189-3-20210226","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2796.1998.00281.x","article-title":"Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1.","volume":"243","author":"Jensen","year":"1998","journal-title":"J Intern Med"},{"key":"R196-3-20210226","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000335591","article-title":"ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes.","volume":"95","author":"Jensen","year":"2012","journal-title":"Neuroendocrinology"},{"issue":"5B","key":"R197-3-20210226","first-page":"90","article-title":"Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric acid hypersecretory states.","volume":"77","author":"Jensen","year":"1984","journal-title":"Am J Med"},{"key":"R198-3-20210226","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMe1013903","article-title":"Promising advances in the treatment of malignant pancreatic endocrine tumors.","volume":"364","author":"Jensen","year":"2011","journal-title":"N Engl J Med"},{"key":"R201-3-20210226","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000098009","article-title":"Gastrinoma (duodenal and pancreatic).","volume":"84","author":"Jensen","year":"2006","journal-title":"Neuroendocrinology"},{"key":"R202-3-20210226","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1677\/ERC-07-0015","article-title":"MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1.","volume":"14","author":"Jiang","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"R203-3-20210226","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S1072-7515(99)00162-3","article-title":"A personal experience with pancreatic and duodenal neuroendocrine tumors.","volume":"189","author":"Jordan","year":"1999","journal-title":"J Am Coll Surg"},{"key":"R204-3-20210226","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1440-1673.1988.tb02765.x","article-title":"Thymic carcinoid in a case of Zollinger-Ellison syndrome. A case report.","volume":"32","author":"Jose","year":"1988","journal-title":"Australas Radiol"},{"key":"R205-3-20210226","first-page":"635","article-title":"Carcinoma of two parathyroid glands caused by a novel MEN1 gene mutationa rare feature of the MEN 1 syndrome.","volume":"47","author":"Juodele","year":"2011","journal-title":"Medicina (Kaunas)"},{"key":"R206-3-20210226","first-page":"258","article-title":"Multiple endocrine neoplasia 1current recommendations for diagnosis and treatment.","volume":"114","author":"Kaczirek","year":"2002","journal-title":"Wien Klin Wochenschr"},{"key":"R207-3-20210226","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF01658530","article-title":"Gastrinomas: a 42-year experience.","volume":"14","author":"Kaplan","year":"1990","journal-title":"World J Surg"},{"key":"R208-3-20210226","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1055\/s-2000-8146","article-title":"Concepts for screening and diagnostic follow-up in multiple endocrine neoplasia type 1 (MEN).","volume":"108","author":"Karges","year":"2000","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R209-3-20210226","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2169\/internalmedicine.35.285","article-title":"Multiple endocrine neoplasia type 1 associated with spinal ependymoma.","volume":"35","author":"Kato","year":"1996","journal-title":"Intern Med"},{"key":"R210-3-20210226","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1016\/j.ijcard.2006.05.033","article-title":"Primary hyperparathyroidism and the cardiovascular system.","volume":"113","author":"Kiernan","year":"2006","journal-title":"Int J Cardiol"},{"key":"R211-3-20210226","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1067\/msy.2001.118379","article-title":"Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1.","volume":"130","author":"Kivlen","year":"2001","journal-title":"Surgery"},{"key":"R212-3-20210226","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/1097-0142(19860501)57:9<1824::AID-CNCR2820570920>3.0.CO;2-Q","article-title":"Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type I. An immunocytochemical study of nine patients.","volume":"57","author":"Kloppel","year":"1986","journal-title":"Cancer"},{"key":"R213-3-20210226","first-page":"703","article-title":"An autopsy case of MEN syndrome-type-1unusual complication with gastric cancer.","volume":"6","author":"Kobayashi","year":"1988","journal-title":"Pathol Clin Med"},{"key":"R214-3-20210226","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF02662474","article-title":"Resected invasive thymoma with multiple endocrine neoplasia type 1.","volume":"54","author":"Kojima","year":"2006","journal-title":"Jpn J Thorac Cardiovasc Surg"},{"key":"R215-3-20210226","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s002680020170","article-title":"Predictive genetic screening and clinical findings in multiple endocrine neoplasia type I families.","volume":"25","author":"Kopp","year":"2001","journal-title":"World J Surg"},{"key":"R216-3-20210226","first-page":"161","article-title":"Fatal thrombotic thrombocytopenic purpura (TTP) presenting concurrently with metastatic multiple endocrine neoplasia (MEN) type I.","volume":"10","author":"Kouides","year":"1996","journal-title":"Hematopathol Mol Hematol"},{"key":"R217-3-20210226","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00268-006-0360-y","article-title":"Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1.","volume":"30","author":"Kouvaraki","year":"2006","journal-title":"World J Surg"},{"key":"R218-3-20210226","first-page":"1080","article-title":"Hyperparathyroidism in multiple endocrine neoplasia syndrome.","volume":"112","author":"Kraimps","year":"1992","journal-title":"Surgery"},{"key":"R219-3-20210226","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1001\/archsurg.2012.1261","article-title":"Lymph nodes and survival in pancreatic neuroendocrine tumors.","volume":"147","author":"Krampitz","year":"2012","journal-title":"Arch Surg"},{"key":"R220-3-20210226","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2214\/ajr.143.3.585","article-title":"Localization of islet cell tumors by dynamic CT: comparison with plain CT, arteriography, sonography and venous sampling.","volume":"143","author":"Krudy","year":"1984","journal-title":"Am J Roentgenol"},{"key":"R221-3-20210226","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/MPA.0b013e3181ebb168","article-title":"NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.","volume":"39","author":"Kulke","year":"2010","journal-title":"Pancreas"},{"key":"R222-3-20210226","first-page":"149","article-title":"Haemorrhagic necrosis of a pituitary adenoma in a case of multiple endocrine neoplasia (authors transl).","volume":"138","author":"Labauge","year":"1982","journal-title":"Rev Neurol (Paris)"},{"key":"R224-3-20210226","first-page":"270","article-title":"Familial multiple endocrine neoplasia type I (Wermers syndrome).","volume":"21","author":"Lamers","year":"1978","journal-title":"Neth J Med"},{"key":"R225-3-20210226","first-page":"94","article-title":"The Zollinger-Ellison syndrome.","volume":"17","author":"Lamers","year":"1974","journal-title":"Neth J Med"},{"key":"R226-3-20210226","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0002-9343(78)90580-6","article-title":"Prevalence of endocrine abnormalities in patients with the Zollinger-Ellison syndrome and in their families.","volume":"64","author":"Lamers","year":"1978","journal-title":"Am J Med"},{"key":"R227-3-20210226","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1056\/NEJM198403223101205","article-title":"Omeprazole in Zollinger-Ellison syndrome: effects of a single dose and of long term treatment in patients resistant to histamine H2-receptor antagonists.","volume":"310","author":"Lamers","year":"1984","journal-title":"N Engl J Med"},{"key":"R228-3-20210226","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00268-002-6492-4","article-title":"Adrenal involvement in multiple endocrine neoplasia type 1.","volume":"26","author":"Langer","year":"2002","journal-title":"World J Surg"},{"key":"R229-3-20210226","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/00042737-199811000-00008","article-title":"Gastrinomas and the change in their presentation and management in Northern Ireland, UK, from 1970 to 1996.","volume":"10","author":"Larkin","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R230-3-20210226","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1097\/00000478-199611000-00009","article-title":"Immunohistochemical study of 100 pancreatic tumors in 28 patients with multiple endocrine neoplasia, type 1.","volume":"20","author":"LeBodic","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R231-3-20210226","first-page":"1602","article-title":"Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy.","volume":"40","author":"Lebtahi","year":"1999","journal-title":"J Nucl Med"},{"key":"R232-3-20210226","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/gut.33.9.1275","article-title":"Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome.","volume":"33","author":"Lehy","year":"1992","journal-title":"Gut"},{"key":"R233-3-20210226","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0399-8320(04)95184-6","article-title":"Prevalence, characteristics and prognosis of MEN 1-associated glucagonomas, VIPomas, and somatostatinomas: study from the GTE (Groupe des Tumeurs Endocrines) registry.","volume":"28","author":"Levy-Bohbot","year":"2004","journal-title":"Gastroenterol Clin Biol"},{"issue":"Suppl 1","key":"R234-3-20210226","first-page":"1","article-title":"Endocrine tumors of the pancreas (EPTs) in multiple endocrine neoplasia (MEN1): up-date on prognostic factors, diagnostic procedures and treatment.","volume":"68","author":"Libe","year":"2007","journal-title":"Ann Endocrinol (Paris)"},{"key":"R236-3-20210226","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/01.COC.0000020584.56294.72","article-title":"Atypical thymic carcinoid and malignant somatostatinoma in type I multiple endocrine neoplasia syndrome: case report.","volume":"26","author":"Lin","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"R237-3-20210226","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.pai.0000210416.53493.0f","article-title":"Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin.","volume":"15","author":"Lin","year":"2007","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R238-3-20210226","first-page":"383","article-title":"Long term follow up of patients with Zollinger-Ellison syndrome (ZES).","volume":"155","author":"Lind","year":"1989","journal-title":"Acta Chir Scand"},{"key":"R239-3-20210226","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1040-8428(84)80017-7","article-title":"Multiple endocrine neoplasia syndromes.","volume":"2","author":"Lips","year":"1984","journal-title":"Crit Rev Oncol Hematol"},{"key":"R240-3-20210226","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archsurg.1967.01330080132033","article-title":"Perforation of a gastrojejunal ulcer into the pericardium.","volume":"94","author":"Liu","year":"1967","journal-title":"Arch Surg"},{"key":"R241-3-20210226","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1067\/msy.2000.109729","article-title":"Value of intra-arterial calcium stimulated venous sampling for regionalization of pancreatic insulinomas.","volume":"128","author":"Lo","year":"2000","journal-title":"Surgery"},{"key":"R242-3-20210226","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1148\/radiology.178.3.1994415","article-title":"Zollinger-Ellison syndrome: prospective assessment of abdominal US in the localization of gastrinomas.","volume":"178","author":"London","year":"1991","journal-title":"Radiology"},{"key":"R243-3-20210226","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/PAS.0b013e3181da0a20","article-title":"PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.","volume":"34","author":"Long","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R244-3-20210226","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00423-011-0828-1","article-title":"Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1.","volume":"396","author":"Lopez","year":"2011","journal-title":"Langenbecks Arch Surg"},{"key":"R245-3-20210226","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1002\/jbmr.125","article-title":"Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism.","volume":"25","author":"Lourenco","year":"2010","journal-title":"J Bone Miner Res"},{"key":"R246-3-20210226","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1590\/S1807-59322007000400014","article-title":"The impact of clinical and genetic screenings on the management of the multiple endocrine neoplasia type 1.","volume":"62","author":"Lourenco","year":"2007","journal-title":"Clinics (Sao Paulo)"},{"key":"R247-3-20210226","first-page":"1043","article-title":"Pancreatic islet cell tumor metastasis in multiple endocrine neoplasia type 1: correlation with primary tumor size.","volume":"125","author":"Lowney","year":"1999","journal-title":"Surgery"},{"key":"R248-3-20210226","first-page":"5272","article-title":"Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients.","volume":"56","author":"Lubensky","year":"1996","journal-title":"Cancer Res"},{"key":"R249-3-20210226","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF02961039","article-title":"A family with multiple endocrine neoplasia type 1.","volume":"152","author":"Lucey","year":"1983","journal-title":"Ir J Med Sci"},{"key":"R250-3-20210226","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0039-6060(05)80102-3","article-title":"A prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia-type 1.","volume":"118","author":"MacFarlane","year":"1995","journal-title":"Surgery"},{"key":"R251-3-20210226","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2265.2007.02934.x","article-title":"Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers.","volume":"67","author":"Machens","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R252-3-20210226","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/gut.43.3.422","article-title":"Prognostic factors in patients with endocrine tumours of the duodenopancreatic area.","volume":"43","author":"Madeira","year":"1998","journal-title":"Gut"},{"key":"R253-3-20210226","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/jso.21196","article-title":"Hepatic ablation for neuroendocrine tumor metastases.","volume":"100","author":"Maithel","year":"2009","journal-title":"J Surg Oncol"},{"key":"R254-3-20210226","first-page":"475","article-title":"The MEN-I syndrome: an all or none phenomenon Surgery.","volume":"86","author":"Majewski","year":"1979","journal-title":""},{"key":"R255-3-20210226","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/0016-5085(83)90375-X","article-title":"Medical and surgical options in the management of patients with gastrinoma.","volume":"84","author":"Malagelada","year":"1983","journal-title":"Gastroenterology"},{"key":"R256-3-20210226","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0720-048X(90)90116-S","article-title":"Contrast MRI in multiple endocrine neoplasia type 1 (MEN) associated with renal cell carcinoma.","volume":"10","author":"Mallek","year":"1990","journal-title":"Eur J Radiol"},{"key":"R257-3-20210226","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/BF01655552","article-title":"Parathyroid surgery in the multiple endocrine neoplasia type I syndrome: choice of surgical procedure.","volume":"10","author":"Malmaeus","year":"1986","journal-title":"World J Surg"},{"key":"R258-3-20210226","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1385\/IJGC:23:2:153","article-title":"Carcinoid tumors of the pancreas.","volume":"23","author":"Mao","year":"1998","journal-title":"Int J Pancreatol"},{"key":"R259-3-20210226","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s00259-010-1599-6","article-title":"Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging.","volume":"37","author":"Marini","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R260-3-20210226","first-page":"877","article-title":"Functioning islet cell tumors of the pancreas: 25-year follow up.","volume":"154","author":"Markowitz","year":"1961","journal-title":"Ann Surg"},{"key":"R261-3-20210226","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-129-6-199809150-00011","article-title":"Multiple endocrine neoplasia type 1: clinical and genetic topics.","volume":"129","author":"Marx","year":"1998","journal-title":"Ann Intern Med"},{"key":"R262-3-20210226","first-page":"397","article-title":"Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.","volume":"54","author":"Marx","year":"1999","journal-title":"Recent Prog Horm Res"},{"key":"R263-3-20210226","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1210\/jcem-67-1-149","article-title":"Mitogenic activity on parathyroid cells in plasma from members of a large kindred with multiple endocrine neoplasia type 1.","volume":"67","author":"Marx","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"R264-3-20210226","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00005792-198607000-00003","article-title":"Multiple endocrine neoplasia type I: assessment of laboratory tests to screen for the gene in a large kindred.","volume":"65","author":"Marx","year":"1986","journal-title":"Medicine (Baltimore)"},{"key":"R265-3-20210226","first-page":"461","article-title":"Familial forms of endocrine tumors of the pancreas. A propos of 4 cases in the same family.","volume":"115","author":"Mathis","year":"1989","journal-title":"Chirurgie"},{"key":"R266-3-20210226","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0016-5085(88)90415-5","article-title":"Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective study.","volume":"94","author":"Maton","year":"1988","journal-title":"Gastroenterology"},{"key":"R267-3-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198607033150101","article-title":"Cushings syndrome in patients with Zollinger-Ellison syndrome.","volume":"315","author":"Maton","year":"1986","journal-title":"N Engl J Med"},{"key":"R268-3-20210226","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0016-5085(90)90611-4","article-title":"The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells.","volume":"99","author":"Maton","year":"1990","journal-title":"Gastroenterology"},{"key":"R269-3-20210226","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0016-5085(87)90964-4","article-title":"Role of selective angiography in the management of Zollinger-Ellison syndrome.","volume":"92","author":"Maton","year":"1987","journal-title":"Gastroenterology"},{"key":"R270-3-20210226","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0016-5085(89)91485-6","article-title":"Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study.","volume":"97","author":"Maton","year":"1989","journal-title":"Gastroenterology"},{"key":"R271-3-20210226","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2265.2006.02563.x","article-title":"Multiple endocrine neoplasia type 1 (MEN 1) is associated with an increased prevalence of diabetes mellitus and impaired fasting glucose.","volume":"65","author":"McCallum","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R272-3-20210226","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0016-5085(78)90780-1","article-title":"Report on the United States experience with cimetidine in Zollinger-Ellison syndrome and other hypersecretory states.","volume":"74","author":"McCarthy","year":"1978","journal-title":"Gastroenterology"},{"key":"R273-3-20210226","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1136\/bmj.1.6180.1765","article-title":"Hyperparathyroidism a reversible cause of cimetidine-resistant gastric hypersecretion.","volume":"1","author":"McCarthy","year":"1979","journal-title":"Br Med J"},{"key":"R274-3-20210226","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0002-9440(10)61788-9","article-title":"Multiple leiomyomas of the esophagus, lung, and uterus in multiple endocrine neoplasia type 1.","volume":"159","author":"McKeeby","year":"2001","journal-title":"Am J Pathol"},{"key":"R275-3-20210226","first-page":"256","article-title":"Changing concepts in the presentation, diagnosis and management of the Zollinger-Ellison syndrome.","volume":"52","author":"Mee","year":"1983","journal-title":"Q J Med"},{"key":"R276-3-20210226","first-page":"1183","article-title":"Long-term prognosis of Zollinger-Ellison syndrome in multiple endocrine neoplasia.","volume":"114","author":"Melvin","year":"1993","journal-title":"Surgery"},{"key":"R277-3-20210226","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1111\/j.1572-0241.2001.05325.x","article-title":"Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.","volume":"96","author":"Metz","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R279-3-20210226","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1053\/j.gastro.2008.05.047","article-title":"Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors.","volume":"135","author":"Metz","year":"2008","journal-title":"Gastroenterology"},{"key":"R281-3-20210226","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/0016-5085(92)91170-9","article-title":"Currently used doses of omeprazole in Zollinger-Ellison syndrome are too high.","volume":"103","author":"Metz","year":"1992","journal-title":"Gastroenterology"},{"key":"R282-3-20210226","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF01655106","article-title":"Control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndrome.","volume":"17","author":"Metz","year":"1993","journal-title":"World J Surg"},{"key":"R283-3-20210226","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF01307541","article-title":"Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome.","volume":"38","author":"Metz","year":"1993","journal-title":"Dig Dis Sci"},{"key":"R284-3-20210226","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2036.1993.tb00140.x","article-title":"Use of omeprazole in Zollinger-Ellison: a prospective nine-year study of efficacy and safety.","volume":"7","author":"Metz","year":"1993","journal-title":"Aliment Pharmacol Ther"},{"key":"R285-3-20210226","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/jama.1962.03050110022004","article-title":"Peptic ulcer as a manifestation of familial polyendocrine disease.","volume":"179","author":"Mieher","year":"1962","journal-title":"JAMA"},{"key":"R286-3-20210226","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000051856","article-title":"Natural history of neuroendocrine enteropancreatic tumors.","volume":"62","author":"Mignon","year":"2000","journal-title":"Digestion"},{"key":"R287-3-20210226","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1365-2796.1998.00287.x","article-title":"Diagnostic and therapeutic criteria in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1.","volume":"243","author":"Mignon","year":"1998","journal-title":"J Intern Med"},{"key":"R288-3-20210226","first-page":"S98","article-title":"Natural history of gastrinoma: lessons from the past.","volume":"31","author":"Mignon","year":"1999","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"R291-3-20210226","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/BF01655562","article-title":"Current approach to the management of tumoral process in patients with gastrinoma.","volume":"10","author":"Mignon","year":"1986","journal-title":"World J Surg"},{"key":"R292-3-20210226","first-page":"A417","article-title":"Preoperative serum gastrin level as a prognostic indicator in Zollinger-Ellison syndrome.","volume":"110","author":"Miller","year":"1996","journal-title":"Gastroenterology"},{"key":"R293-3-20210226","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1148\/radiology.182.1.1727289","article-title":"Zollinger-Ellison syndrome: technique, results and complications of portal venous sampling.","volume":"182","author":"Miller","year":"1992","journal-title":"Radiology"},{"key":"R294-3-20210226","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-3-642-75858-4_13","article-title":"Zollinger-Ellison syndrome. Advances in diagnosis and treatment.","volume":"99","author":"Miller","year":"1991","journal-title":"Handbk Exp Pharmacol"},{"key":"R295-3-20210226","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0016-5085(90)90823-J","article-title":"Reflux esophagitis in patients with Zollinger-Ellison syndrome.","volume":"98","author":"Miller","year":"1990","journal-title":"Gastroenterology"},{"key":"R296-3-20210226","first-page":"69","article-title":"Clinical analysis of resected cases of pancreatic endocrine tumors.","volume":"49","author":"Mino","year":"2004","journal-title":"Hokkaido J Surg"},{"key":"R297-3-20210226","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1507\/endocrj.45.753","article-title":"A family of MEN1 with a novel germline missense mutation and benign polymorphisms.","volume":"45","author":"Miyauchi","year":"1998","journal-title":"Endocr J"},{"key":"R298-3-20210226","first-page":"485","article-title":"Multiple endocrine neoplasia. Part I. Wermers syndrome.","volume":"56","author":"Modlin","year":"1979","journal-title":"S Afr Med J"},{"key":"R299-3-20210226","first-page":"80","article-title":"Sequential heptic artery occlusion and chemotherapy for metastatic islet carcinoid tumor and islet cell carcinoma.","volume":"4","author":"Moertel","year":"1985","journal-title":"Proc Am Soc Clin Oncol"},{"key":"R300-3-20210226","first-page":"153","article-title":"Multiple endocrine tumors and Zollinger-Ellison syndrome in families: one or two syndromes A report of two new families.","volume":"11","author":"Moldawer","year":"1962","journal-title":"Metabolism"},{"key":"R301-3-20210226","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00000441-195408000-00008","article-title":"Concomitance of multiple adenomas of the parathyroids and pancreatic islet cells with tumor of the pituitary; a syndrome with familial incidence.","volume":"228","author":"Moldawer","year":"1954","journal-title":"Am J Med Sci"},{"key":"R302-3-20210226","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/bbrc.1995.1196","article-title":"RFLP analysis of human chromosome 11 region q13 in multiple symmetric lipomatosis and multiple endocrine neoplasia type 1-associated lipomas.","volume":"207","author":"Morelli","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"R303-3-20210226","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1177\/000313480907500818","article-title":"Long-term results of a selective surgical approach to management of Zollinger-Ellison syndrome in patients with MEN-1.","volume":"75","author":"Mortellaro","year":"2009","journal-title":"Am Surg"},{"key":"R304-3-20210226","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/BF00311466","article-title":"Multiple endocrine neoplasia type 1 presenting as insulinoma, gastrinoma, and postubulbar duodenal ulcers: report of a case.","volume":"25","author":"Murakami","year":"1995","journal-title":"Surg Today"},{"key":"R305-3-20210226","first-page":"1616","article-title":"Thymic and bronchial neuroendocrine tumors in multiple endocrine neoplasia type 1. GENEM1.","volume":"26","author":"Murat","year":"1997","journal-title":"Presse Med"},{"key":"R306-3-20210226","first-page":"190","article-title":"Wermers syndrome or familial polyendocrine adenomatous hyperplasia (2 anatomo-clinical cases).","volume":"34","author":"Murie","year":"1973","journal-title":"Ann Endocrinol (Paris)"},{"key":"R307-3-20210226","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/0002-9610(60)90425-6","article-title":"Peptic ulceration with associated endocrine tumors.","volume":"100","author":"Murphy","year":"1960","journal-title":"Am J Surg"},{"key":"R308-3-20210226","first-page":"794","article-title":"Multiple endocrine neoplasia, type 1, with pancreatic cholera.","volume":"82","author":"Namihira","year":"1987","journal-title":"Am J Gastroenterol"},{"key":"R309-3-20210226","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1210\/jc.2009-0564","article-title":"Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors.","volume":"94","author":"Newey","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R310-3-20210226","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1517\/14656566.7.2.169","article-title":"The role of proton pump inhibitors in the treatment of Zollinger-Ellison syndrome.","volume":"7","author":"Nieto","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"R311-3-20210226","first-page":"1668","article-title":"Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients.","volume":"52","author":"Nikou","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"R312-3-20210226","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1507\/endocrj.51.75","article-title":"Multiple endocrine neoplasia type 1 with unusual concomitance of various neoplastic disorders.","volume":"51","author":"Nishimura","year":"2004","journal-title":"Endocr J"},{"key":"R313-3-20210226","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/1097-0215(20000815)87:4<463::AID-IJC1>3.0.CO;2-8","article-title":"Malignant melanoma in patients with multiple endocrine neoplasia type 1 and involvement of the MEN1 gene in sporadic melanoma.","volume":"87","author":"Nord","year":"2000","journal-title":"Int J Cancer"},{"key":"R314-3-20210226","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/01.SLA.0000064375.51939.48","article-title":"Possible primary lymph node gastrinomas: occurrence, natural history and predictive factors: a prospective study.","volume":"237","author":"Norton","year":"2003","journal-title":"Ann Surg"},{"key":"R315-3-20210226","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00000658-200110000-00009","article-title":"Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome.","volume":"234","author":"Norton","year":"2001","journal-title":"Ann Surg"},{"key":"R316-3-20210226","first-page":"617","article-title":"Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases or survival in patients with Zollinger-Ellison syndrome (ZES) Ann Surg.","volume":"239","author":"Norton","year":"2004","journal-title":""},{"key":"R317-3-20210226","first-page":"958","article-title":"Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome and multiple endocrine neoplasia Type I: a prospective study.","volume":"102","author":"Norton","year":"1987","journal-title":"Surgery"},{"key":"R318-3-20210226","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00000658-198802000-00008","article-title":"Intraoperative ultrasonographic localization of islet cell tumors. A prospective comparison to palpation.","volume":"207","author":"Norton","year":"1988","journal-title":"Ann Surg"},{"key":"R319-3-20210226","doi-asserted-by":"crossref","first-page":"148","DOI":"10.6004\/jnccn.2006.0015","article-title":"Surgery for gastrinoma and insulinoma in multiple endocrine neoplasia type 1.","volume":"4","author":"Norton","year":"2006","journal-title":"J Natl Compr Cancer"},{"key":"R320-3-20210226","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/01.sla.0000234802.44320.a5","article-title":"Surgery increases survival in patients with gastrinoma.","volume":"244","author":"Norton","year":"2006","journal-title":"Ann Surg"},{"key":"R321-3-20210226","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM199908263410902","article-title":"Surgery to cure the Zollinger-Ellison syndrome.","volume":"341","author":"Norton","year":"1999","journal-title":"N Engl J Med"},{"key":"R322-3-20210226","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF01658992","article-title":"Unresolved surgical issues in the management of patients with the Zollinger-Ellison syndrome.","volume":"15","author":"Norton","year":"1991","journal-title":"World J Surg"},{"key":"R323-3-20210226","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0960-7404(03)00035-5","article-title":"Current surgical management of Zollinger-Ellison syndrome (ZES) in patients without multiple endocrine neoplasia-type 1 (MEN1).","volume":"12","author":"Norton","year":"2003","journal-title":"Surg Oncol"},{"key":"R324-3-20210226","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.sla.0000143252.02142.3e","article-title":"Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome.","volume":"240","author":"Norton","year":"2004","journal-title":"Ann Surg"},{"key":"R325-3-20210226","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1001\/archsurg.138.8.859","article-title":"Morbidity and mortality of aggressive resections in patients with advanced neuroendocrine tumors.","volume":"138","author":"Norton","year":"2003","journal-title":"Arch Surg"},{"key":"R326-3-20210226","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.surg.2004.06.057","article-title":"Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgery.","volume":"136","author":"Norton","year":"2004","journal-title":"Surgery"},{"key":"R327-3-20210226","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00000658-198604000-00003","article-title":"Aggressive resection of metastatic disease in selected patients with malignant gastrinoma.","volume":"203","author":"Norton","year":"1986","journal-title":"Ann Surg"},{"key":"R328-3-20210226","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/SLA.0b013e31815efda5","article-title":"Prospective study of surgery for primary hyperaparathyroidism (HPT) in multiple endocrine neoplasia type 1 (MEN1), and Zollinger-Ellison syndrome (ZES): longterm outcome of a more virulent form of HPT.","volume":"247","author":"Norton","year":"2008","journal-title":"Ann Surgery"},{"key":"R329-3-20210226","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.surg.2003.07.025","article-title":"Aggressive surgery for metastatic liver neuroendocrine tumors.","volume":"134","author":"Norton","year":"2003","journal-title":"Surgery"},{"key":"R330-3-20210226","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/BF00353743","article-title":"Surgical management of insulinoma associated with multiple endocrine neoplasia type 1.","volume":"18","author":"ORiordain","year":"1994","journal-title":"World J Surg"},{"key":"R331-3-20210226","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/030089161009600530","article-title":"Neuroendocrine tumors (NETs): historical overview and epidemiology.","volume":"96","author":"Oberg","year":"2010","journal-title":"Tumori"},{"key":"R332-3-20210226","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0002-9343(82)90401-6","article-title":"Peptide hormone markers in screening for endocrine tumors in multiple endocrine adenomatosis type I.","volume":"73","author":"Oberg","year":"1982","journal-title":"Am J Med"},{"key":"R333-3-20210226","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1002\/1097-0142(19941015)74:8<2374::AID-CNCR2820740824>3.0.CO;2-0","article-title":"A metastatic neuroendocrine anaplastic small cell tumor in a patient with multiple endocrine neoplasia type 1 syndrome.","volume":"74","author":"OByrne","year":"1994","journal-title":"Cancer"},{"key":"R334-3-20210226","first-page":"915","article-title":"A case of malignant insulinoma assocated with multiple endocrine neoplasia type 1 in a patient whose blood glucose has been well managed with diazoxide and octreotide.","volume":"41","author":"Ogino","year":"1988","journal-title":"J Japan Diabetes Soc"},{"key":"R336-3-20210226","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1523-1747.1998.00140.x","article-title":"Cutaneous tumors in patients with multiple endocrine neoplasia type 1 show allelic deletion of the MEN1 gene.","volume":"110","author":"Pack","year":"1998","journal-title":"J Invest Dermatol"},{"key":"R337-3-20210226","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/annonc\/mdj113","article-title":"Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma.","volume":"17","author":"Panzuto","year":"2006","journal-title":"Ann Oncol"},{"key":"R338-3-20210226","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1677\/erc.1.01017","article-title":", Tornatore V, Milione M, Angeletti S, Cattaruzza MS, Ziparo V, Bordi C, Pederzoli P, Delle Fave G. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization.","volume":"12","author":"Panzuto","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"R339-3-20210226","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1677\/ERC-08-0017","article-title":"Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.","volume":"15","author":"Pape","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"R340-3-20210226","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/cncr.23549","article-title":"Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.","volume":"113","author":"Pape","year":"2008","journal-title":"Cancer"},{"key":"R341-3-20210226","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00042737-200102000-00021","article-title":"A malignant gastrointestinal stromal tumour in a patient with multiple endocrine neoplasia type 1.","volume":"13","author":"Papillon","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R342-3-20210226","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0344-0338(11)80767-3","article-title":"Multidirectional carcinoma of the thymus with neuroendocrine and sarcomatoid components and carcinoid syndrome.","volume":"187","author":"Paties","year":"1991","journal-title":"Pathol Res Pract"},{"key":"R343-3-20210226","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000335597","article-title":"ENETS consensus guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.","volume":"95","author":"Pavel","year":"2012","journal-title":"Neuroendocrinology"},{"key":"R344-3-20210226","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1053\/gast.2002.34231","article-title":"Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas.","volume":"123","author":"Peghini","year":"2002","journal-title":"Gastroenterology"},{"key":"R345-3-20210226","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1091-255X(98)80039-5","article-title":"Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients.","volume":"2","author":"Phan","year":"1998","journal-title":"J Gastrointest Surg"},{"key":"R346-3-20210226","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2265.2008.03324.x","article-title":"Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.","volume":"70","author":"Pieterman","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R347-3-20210226","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF01655107","article-title":"Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I.","volume":"17","author":"Pipeleers-Marichal","year":"1993","journal-title":"World J Surg"},{"key":"R348-3-20210226","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1056\/NEJM199003153221103","article-title":"Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome.","volume":"322","author":"Pipeleers-Marichal","year":"1990","journal-title":"N Engl J Med"},{"key":"R349-3-20210226","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/BF01296084","article-title":"Prospective comparative study of ability of MR imaging and other imaging modalities to localize tumors in patients with Zollinger-Ellison syndrome.","volume":"38","author":"Pisegna","year":"1993","journal-title":"Dig Dis Sci"},{"key":"R350-3-20210226","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0016-5085(92)90157-T","article-title":"Effects of curative resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.","volume":"102","author":"Pisegna","year":"1992","journal-title":"Gastroenterology"},{"key":"R351-3-20210226","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0016-5085(93)90965-F","article-title":"An evaluation of human recombinant alpha interferon in patients with metastatic gastrinoma.","volume":"105","author":"Pisegna","year":"1993","journal-title":"Gastroenterology"},{"key":"R352-3-20210226","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s002689900430","article-title":"Late outcome of 304 consecutive patients with multiple gland enlargement in primary hyperparathyroidism treated by conservative surgery.","volume":"22","author":"Proye","year":"1998","journal-title":"World J Surg"},{"key":"R353-3-20210226","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/01.mcg.0000159221.77913.ac","article-title":"A follow-up study of patients with Zollinger-Ellison syndrome in the period 1966-2002: effects of surgical and medical treatments on long-term survival.","volume":"39","author":"Quatrini","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"R354-3-20210226","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1365-2265.2011.04134.x","article-title":"A novel deletion of the MEN1 gene in a large family of multiple endocrine neoplasia type 1 (MEN1) with aggressive phenotype.","volume":"75","author":"Raef","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R355-3-20210226","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1634\/theoncologist.2010-0313","article-title":"Targeted therapy in advanced well-differentiated neuroendocrine tumors.","volume":"16","author":"Raut","year":"2011","journal-title":"Oncologist"},{"key":"R356-3-20210226","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMoa1003825","article-title":"Sunitinib Malate for the treatment of pancreatic neuroendocrine tumors.","volume":"364","author":"Raymond","year":"2011","journal-title":"N Engl J Med"},{"key":"R357-3-20210226","first-page":"19","article-title":"A reappraisal of clinical, roentgenographic, and endoscopic features of the Zollinger-Ellison syndrome.","volume":"53","author":"Regan","year":"1978","journal-title":"Mayo Clin Proc"},{"key":"R358-3-20210226","first-page":"3149","article-title":"Adenomatose polyendocrinienne de type I avec tumeur a prolactine revelee par une apoplexie hypophysaire.","volume":"10","author":"Richard","year":"1981","journal-title":"Nouv Presse Med"},{"key":"R359-3-20210226","first-page":"1299","article-title":"Association hyperparathyroidie-syndrome de Zollinger-Ellison.","volume":"11","author":"Rigaud","year":"1982","journal-title":"Nouv Presse Med"},{"key":"R360-3-20210226","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0016-5085(99)70174-5","article-title":"ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis.","volume":"116","author":"Rindi","year":"1999","journal-title":"Gastroenterology"},{"key":"R361-3-20210226","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/archinte.1947.00220090067004","article-title":"Primary hypertrophy and hyperplasia of the parathyroid glands associated with duodenal ulcer.","volume":"79","author":"Rogers","year":"1947","journal-title":"Arch Intern Med"},{"key":"R362-3-20210226","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/1097-0142(197204)29:4<1061::AID-CNCR2820290456>3.0.CO;2-3","article-title":"Mediastinal endocrine neoplasm, of probable thymic origin, related to carcinoid tumor. Clinicopathologic study of 8 cases.","volume":"29","author":"Rosai","year":"1972","journal-title":"Cancer"},{"key":"R363-3-20210226","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/1097-0142(197204)29:4<1075::AID-CNCR2820290457>3.0.CO;2-O","article-title":"Mediastinal endocrine neoplasm in patients with multiple endocrine adenomatosis. A previously unrecognized association.","volume":"29","author":"Rosai","year":"1972","journal-title":"Cancer"},{"key":"R364-3-20210226","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00005792-200105000-00005","article-title":"Gastric secretion in Zollinger-Ellison syndrome: correlation with clinical expression, tumor extent and role in diagnosis. A prospective NIH study of 235 patients and review of the literature in 984 cases.","volume":"80","author":"Roy","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"R365-3-20210226","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00005792-200011000-00004","article-title":"Zollinger-Ellison syndrome: clinical presentation in 261 patients.","volume":"79","author":"Roy","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"R366-3-20210226","first-page":"170","article-title":"Intractable peptic ulcer and endocrine adenomas with pituitary amphophilic hyperplasia.","volume":"48","author":"Rudolf","year":"1960","journal-title":"Surgery"},{"key":"R367-3-20210226","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00006676-199305000-00003","article-title":"Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia.","volume":"8","author":"Ruszniewski","year":"1993","journal-title":"Pancreas"},{"key":"R368-3-20210226","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/cncr.20825","article-title":"Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1.","volume":"103","author":"Sachithanandan","year":"2005","journal-title":"Cancer"},{"key":"R369-3-20210226","first-page":"A41","article-title":"The clinical course of non-functioning pancreatic neuroendocrine tumors in MEN type 1.","volume":"6","author":"Sakurai","year":"2006","journal-title":"J Familial Tumors"},{"key":"R370-3-20210226","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1507\/endocrj.47.569","article-title":"Frequency of facial angiofibromas in Japanese patients with multiple endocrine neoplasia type 1.","volume":"47","author":"Sakurai","year":"2000","journal-title":"Endocr J"},{"key":"R371-3-20210226","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2265.2011.04227.x","article-title":"Consortium of Japan. Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database.","volume":"76","author":"Sakurai","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R372-3-20210226","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/1097-0142(19890801)64:3<741::AID-CNCR2820640329>3.0.CO;2-F","article-title":"Multiple endocrine syndrome type I.","volume":"64","author":"Samaan","year":"1989","journal-title":"Cancer"},{"key":"R373-3-20210226","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/SLA.0b013e3181d3d24a","article-title":"Factors predicting response and survival after yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: a critical appraisal of 48 cases.","volume":"251","author":"Saxena","year":"2010","journal-title":"Ann Surg"},{"key":"R374-3-20210226","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1530\/EJE-07-0635","article-title":"Natural course of small adrenal lesions in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study.","volume":"158","author":"Schaefer","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"R375-3-20210226","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0002-9343(61)90123-1","article-title":"Relationship of multiple endocrine adenomas to the syndrome of ulcerogenic islet cell adenomas (Zollinger-Ellison).","volume":"31","author":"Schmid","year":"1961","journal-title":"Am J Med"},{"key":"R376-3-20210226","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00268-011-1068-9","article-title":"The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review.","volume":"35","author":"Schreinemakers","year":"2011","journal-title":"World J Surg"},{"key":"R377-3-20210226","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/01.sla.0000232556.24258.68","article-title":"Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience.","volume":"245","author":"Schurr","year":"2007","journal-title":"Ann Surg"},{"key":"R378-3-20210226","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archsurg.1991.01410320017001","article-title":"The natural history of multiple endocrine neoplasia type I. Highly uncommon or highly unrecognized.","volume":"126","author":"Shepherd","year":"1991","journal-title":"Arch Surg"},{"key":"R379-3-20210226","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/archsurg.1993.01420220053007","article-title":"Multiple endocrine neoplasm, type 1: Gastrinomas, pancreatic neoplasms, microcarcinoids, the Zollinger-Ellison syndrome, lymph nodes, and hepatic metastases.","volume":"128","author":"Shepherd","year":"1993","journal-title":"Arch Surg"},{"key":"R380-3-20210226","first-page":"1108","article-title":"Management of islet cell tumors in patients with Multiple Endocrine Neoplasia: a prospective study.","volume":"106","author":"Sheppard","year":"1989","journal-title":"Surgery"},{"key":"R381-3-20210226","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2169\/naika.78.357","article-title":"A case of multiple endocrine neoplasia, type 1, with parathyroid adenoma, multinodular adrenal cortical hyperplasia, islet cell tumor and hyperplasia of thyroid with concomitant hypersecretion of gastrin and total glucagon-like immunoreactivity.","volume":"78","author":"Shigematsu","year":"1989","journal-title":"Nihon Naika Gakkai Zasshi"},{"key":"R382-3-20210226","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/cncr.10195","article-title":"Prospective study of the anti-tumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinomas.","volume":"94","author":"Shojamanesh","year":"2002","journal-title":"Cancer"},{"key":"R383-3-20210226","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(71)91824-1","article-title":"Vitamin-B 12 absorption and the Zollinger-Ellison syndrome.","volume":"1","author":"Shum","year":"1971","journal-title":"Lancet"},{"key":"R384-3-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-200201000-00001","article-title":"Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds.","volume":"81","author":"Simonds","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"R385-3-20210226","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2265.2011.04220.x","article-title":"Cushings syndrome in multiple endocrine neoplasia type 1.","volume":"76","author":"Simonds","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R386-3-20210226","first-page":"550","article-title":"Zollinger-Ellison syndrome. Experience in 14 cases and a review of the recent literature.","volume":"83","author":"Sitges Serra","year":"1984","journal-title":"Med Clin (Barc)"},{"key":"R387-3-20210226","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1210\/jcem-73-2-281","article-title":"Multiple endocrine neoplasia type I: a 10-year prospective screening study in four kindreds.","volume":"73","author":"Skogseid","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"R388-3-20210226","first-page":"76","article-title":"Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1.","volume":"75","author":"Skogseid","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"R389-3-20210226","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s002689900133","article-title":"Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type 1.","volume":"20","author":"Skogseid","year":"1996","journal-title":"World J Surg"},{"key":"R390-3-20210226","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0039-6060(05)80117-5","article-title":"Adrenal lesion in multiple endocrine neoplasia type 1.","volume":"118","author":"Skogseid","year":"1995","journal-title":"Surgery"},{"key":"R391-3-20210226","first-page":"160","article-title":"The Zollinger-Ellison syndrome.","volume":"37","author":"Smith","year":"1965","journal-title":"Ann R Coll Surg Engl"},{"key":"R392-3-20210226","first-page":"285","article-title":"Evaluation of 342 cases of mediastialthymic carcinoids collected from literature: a comparative study between typical carcinoids and atypical varieties.","volume":"5","author":"Soga","year":"1999","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"R393-3-20210226","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00000478-199006000-00001","article-title":"Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association.","volume":"14","author":"Solcia","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"R394-3-20210226","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/gut.20.2.154","article-title":"Gynaecomastia associated with cimetidine.","volume":"20","author":"Spence","year":"1979","journal-title":"Gut"},{"key":"R395-3-20210226","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/PAS.0b013e31818d7d8b","article-title":"Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors.","volume":"33","author":"Srivastava","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R396-3-20210226","first-page":"213","article-title":"Islet cell tumors.","volume":"5","author":"Stabile","year":"1997","journal-title":"Gastroenterologist"},{"key":"R397-3-20210226","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archsurg.1980.01380090058014","article-title":"Serum gastrin and human chorionic gonadotropin in the Zollinger-Ellison syndrome.","volume":"115","author":"Stabile","year":"1980","journal-title":"Arch Surg"},{"key":"R398-3-20210226","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0002-9610(85)80024-6","article-title":"Benign and malignant gastrinoma.","volume":"49","author":"Stabile","year":"1985","journal-title":"Am J Surg"},{"key":"R399-3-20210226","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/imj.1967.16.4.278","article-title":"Problems of the syndrome of familial multiple endocrine adenomas.","volume":"16","author":"Stocks","year":"1967","journal-title":"Australas Ann Med"},{"key":"R400-3-20210226","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1159\/000197899","article-title":"Survival and prognostic factor analysis of 146 metastatic neuroendocrine tumors of the mid-gut.","volume":"89","author":"Strosberg","year":"2009","journal-title":"Neuroendocrinology"},{"key":"R401-3-20210226","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/107327481101800207","article-title":"A review of systemic and liver-directed therapies for metastatic neuroendocrine tumors of the gastroenteropancreatic tract.","volume":"18","author":"Strosberg","year":"2011","journal-title":"Cancer Control"},{"key":"R402-3-20210226","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/cncr.25425","article-title":"First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas.","volume":"117","author":"Strosberg","year":"2011","journal-title":"Cancer"},{"key":"R403-3-20210226","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00000658-199308000-00004","article-title":"A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas.","volume":"218","author":"Sugg","year":"1993","journal-title":"Ann Surg"},{"key":"R404-3-20210226","first-page":"611","article-title":"Intractable peptic ulcer in hereditary endocrine-ulcer disease: Gastrin content of endocrine tissues.","volume":"36","author":"Summerskill","year":"1961","journal-title":"Proc Staff Meetings Mayo Clin"},{"key":"R405-3-20210226","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1200\/JCO.1997.15.6.2420","article-title":"Growth of newly diagnosed, untreated metastatic gastrinomas and predictors of growth patterns.","volume":"15","author":"Sutliff","year":"1997","journal-title":"J Clin Oncol"},{"key":"R406-3-20210226","first-page":"4","article-title":"The latest aspects of MEN1.","volume":"28","author":"Suzuki","year":"2011","journal-title":"Endocrine Surgery"},{"key":"R407-3-20210226","first-page":"82","article-title":"Long-term postoperative follow-up for patients with familial hyperparathyroidism.","volume":"5","author":"Suzuki","year":"2005","journal-title":"J Familial Tumors"},{"key":"R408-3-20210226","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2169\/internalmedicine.45.1427","article-title":"Multiple endocrine neoplasia type I and Cushings syndrome due to an aggressive ACTH producing thymic carcinoid.","volume":"45","author":"Takagi","year":"2006","journal-title":"Intern Med"},{"key":"R409-3-20210226","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0344-0338(11)80689-8","article-title":"MEN type 1 associated with mediastinal carcinoid producing parathyroid hormone, calcitonin and chorionic gonadotropin.","volume":"189","author":"Takayama","year":"1993","journal-title":"Pathol Res Pract"},{"key":"R410-3-20210226","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2169\/internalmedicine.47.1226","article-title":"Mediastinal seminoma in a patient with multiple endocrine neoplasia type 1.","volume":"47","author":"Tanabe","year":"2008","journal-title":"Intern Med"},{"key":"R411-3-20210226","first-page":"1087","article-title":"Surgical treatments for 7 pituitary adenomas in multiple endocrine neoplasia type 1.","volume":"28","author":"Tanaka","year":"2000","journal-title":"No Shinkei Geka"},{"key":"R412-3-20210226","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2796.1998.00329.x","article-title":"Thymic carcinoids in multiple endocrine neoplasia type 1.","volume":"243","author":"Teh","year":"1998","journal-title":"J Intern Med"},{"key":"R413-3-20210226","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00005792-199701000-00002","article-title":"Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1.","volume":"76","author":"Teh","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"R414-3-20210226","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00000658-199807000-00015","article-title":"Thymic carcinoids in multiple endocrine neoplasia type 1.","volume":"228","author":"Teh","year":"1998","journal-title":"Ann Surg"},{"key":"R415-3-20210226","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1148\/radiology.202.1.8988205","article-title":"Distinguishing small hepatic hemangiomas from vascular liver metastases in patients with gastrinoma: use of a somatostatin-receptor scintigraphic agent.","volume":"202","author":"Termanini","year":"1997","journal-title":"Radiology"},{"key":"R416-3-20210226","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/gast.1997.v112.pm9024287","article-title":"Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management.","volume":"112","author":"Termanini","year":"1997","journal-title":"Gastroenterology"},{"key":"R417-3-20210226","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0002-9343(98)00087-4","article-title":"Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome.","volume":"104","author":"Termanini","year":"1998","journal-title":"Am J Med"},{"key":"R418-3-20210226","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0889-8529(05)70150-X","article-title":"Multiple endocrine neoplasia type 1.","volume":"29","author":"Thakker","year":"2000","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R419-3-20210226","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.beem.2010.07.003","article-title":"Multiple endocrine neoplasia type 1 (MEN1).","volume":"24","author":"Thakker","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R420-3-20210226","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1210\/jc.2007-0476","article-title":"Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases.","volume":"92","author":"Tham","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R421-3-20210226","first-page":"1086","article-title":"Location, incidence and malignant potential of duodenal gastrinomas.","volume":"110","author":"Thom","year":"1991","journal-title":"Surgery"},{"key":"R422-3-20210226","first-page":"1002","article-title":"Prospective study of the use of intraarterial secretin injection and portal venous sampling to localize duodenal gastrinomas.","volume":"112","author":"Thom","year":"1992","journal-title":"Surgery"},{"key":"R423-3-20210226","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1572-0241.2006.00367.x","article-title":"Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.","volume":"101","author":"Thomas-Marques","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R424-3-20210226","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/00000658-198305000-00014","article-title":"The role of surgery in the Zollinger-Ellison syndrome.","volume":"197","author":"Thompson","year":"1983","journal-title":"Ann Surg"},{"key":"R425-3-20210226","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2796.1998.00307.x","article-title":"Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both.","volume":"243","author":"Thompson","year":"1998","journal-title":"J Intern Med"},{"key":"R427-3-20210226","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/bjs.1800750222","article-title":"Total pancreatectomy in the MEN-1 syndrome.","volume":"75","author":"Tisell","year":"1988","journal-title":"Br J Surg"},{"key":"R428-3-20210226","first-page":"150","article-title":"Case Report No.143: one case of multiple endosecretory-adenomatosis accompanied with ventricula ependymoma.","volume":"14","author":"Tobimatsu","year":"2004","journal-title":"Clin Calcium"},{"key":"R429-3-20210226","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1093\/annonc\/mdi358","article-title":"Endocrine pancreatic tumors: factors correlated with survival.","volume":"16","author":"Tomassetti","year":"2005","journal-title":"Ann Oncol"},{"key":"R430-3-20210226","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1046\/j.1365-2036.2000.00738.x","article-title":"Treatment of gastroenteropancratic neuroendocrine tumours with octreotide LAR.","volume":"14","author":"Tomassetti","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"R431-3-20210226","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.sla.0000218073.77254.62","article-title":"Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias.","volume":"244","author":"Tonelli","year":"2006","journal-title":"Ann Surg"},{"key":"R432-3-20210226","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2169\/internalmedicine.35.849","article-title":"Multiple endocrine neoplasia type 1 associated with malignant lymphoma and other complications.","volume":"35","author":"Toshimori","year":"1996","journal-title":"Intern Med"},{"key":"R433-3-20210226","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.sla.0000197715.96762.68","article-title":"Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas.","volume":"243","author":"Triponez","year":"2006","journal-title":"Ann Surg"},{"key":"R434-3-20210226","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s00268-005-0354-9","article-title":"Is surgery beneficial for MEN1 patients with small (2 cm), nonfunctioning pancreaticoduodenal endocrine tumor An analysis of 65 patients from the GTE.","volume":"30","author":"Triponez","year":"2006","journal-title":"World J Surg"},{"key":"R435-3-20210226","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/PAS.0b013e31815ade45","article-title":"Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.","volume":"32","author":"Trouillas","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R436-3-20210226","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/qjmed\/89.9.653","article-title":"Clinical studies of multiple endocrine neoplasia type 1 (MEN1).","volume":"89","author":"Trump","year":"1996","journal-title":"Q J Med"},{"key":"R437-3-20210226","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2169\/internalmedicine.42.1112","article-title":"A novel missense mutation of the MEN1 gene in a multiple endocrine neoplasia type 1 patient associated with carcinoid syndrome.","volume":"42","author":"Ukita","year":"2003","journal-title":"Intern Med"},{"key":"R438-3-20210226","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1210\/jcem-13-1-20","article-title":"Multiple endocrine adenomas: report of 8 cases in which the parathyroids, pituitary and pancreatic islets were involved.","volume":"13","author":"Underdahl","year":"1953","journal-title":"J Clin Endocrinol Metab"},{"key":"R439-3-20210226","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2265.1999.00648.x","article-title":"Multiple endocrine neoplasia type 1 (MEN1): clinical heterogeneity in a large family with a nonsense mutation in the MEN1 gene (Trp471Stop).","volume":"50","author":"Valdes","year":"1999","journal-title":"Clin Endocrinol"},{"key":"R440-3-20210226","first-page":"971","article-title":"Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1.","volume":"100","author":"Van Heerden","year":"1986","journal-title":"Surgery"},{"key":"R441-3-20210226","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1210\/jc.2011-1563","article-title":"Improved control of severe hypoglycemia in patients with malignant insulinomas by Peptide receptor radionuclide therapy.","volume":"96","author":"van Schaik","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R442-3-20210226","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2265.2011.04166.x","article-title":"Increased prevalence of impaired fasting glucose in MEN1 gene mutation carriers.","volume":"76","author":"van Wijk","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R443-3-20210226","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0002-9343(72)90071-X","article-title":"Familial nesidioblastosis as the predominant manifestation of multiple endocrine adenomatosis.","volume":"52","author":"Vance","year":"1972","journal-title":"Am J Med"},{"key":"R444-3-20210226","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1001\/archinte.1989.00390120069014","article-title":"Screening for the multiple endocrine neoplasia syndrome type I. A study of 11 kindreds in the Netherlands.","volume":"149","author":"Vasen","year":"1989","journal-title":"Arch Intern Med"},{"key":"R445-3-20210226","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1445-2197.1985.tb00923.x","article-title":"The Zollinger-Ellison syndrome: a review of the St. Vincents hospital, Melbourne experience.","volume":"55","author":"Vellar","year":"1985","journal-title":"Aust N Z J Surg"},{"key":"R446-3-20210226","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/1097-0142(19900115)65:2<354::AID-CNCR2820650229>3.0.CO;2-N","article-title":"Islet cell carcinoma of the pancreas. A study of 98 patients.","volume":"65","author":"Venkatesh","year":"1990","journal-title":"Cancer"},{"key":"R447-3-20210226","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1210\/jcem.87.2.8145","article-title":"Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.","volume":"87","author":"Verges","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R448-3-20210226","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1530\/EJE-07-0195","article-title":"Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation.","volume":"157","author":"Vierimaa","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"R449-3-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0147-0272(82)80010-X","article-title":"multiple endocrine neoplasias.","volume":"7","author":"Vieto","year":"1982","journal-title":"Curr Probl Cancer"},{"key":"R450-3-20210226","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/0016-5085(88)90670-1","article-title":"Prospective study of chemotherapy in patients with metastatic gastrinoma.","volume":"94","author":"von Schrenck","year":"1988","journal-title":"Gastroenterology"},{"key":"R451-3-20210226","first-page":"919","article-title":"Multiple endocrine neoplasia type 1: atypical presentation, clinical course, and genetic analysis of multiple tumors.","volume":"12","author":"Vortmeyer","year":"1999","journal-title":"Mod Pathol"},{"key":"R452-3-20210226","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ejim.2005.09.008","article-title":"Patients with MEN-1 are more insulin-resistant than their non-affected relatives.","volume":"16","author":"Wagner","year":"2005","journal-title":"Eur J Intern Med"},{"key":"R453-3-20210226","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00423-006-0124-7","article-title":"Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening.","volume":"392","author":"Waldmann","year":"2007","journal-title":"Langenbecks Arch Surg"},{"key":"R454-3-20210226","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/1752-1947-2-354","article-title":"Fast-growing pancreatic neuroendocrine carcinoma in a patient with multiple endocrine neoplasia type 1: a case report.","volume":"2","author":"Waldmann","year":"2008","journal-title":"J Med Case Reports"},{"key":"R455-3-20210226","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/BF03346443","article-title":"Cardiovascular aspects of primary hyperparathyroidism.","volume":"31","author":"Walker","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"R456-3-20210226","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0016-5085(87)90963-2","article-title":"Prospective study of the ability of computerized axial tomography to localize gastrinomas in patients with Zollinger-Ellison syndrome.","volume":"92","author":"Wank","year":"1987","journal-title":"Gastroenterology"},{"key":"R457-3-20210226","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/humu.10092","article-title":"Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein.","volume":"20","author":"Wautot","year":"2002","journal-title":"Hum Mutat"},{"key":"R458-3-20210226","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0002-9610(68)90507-2","article-title":"Zollinger-Ellison syndrome. An analysis of twenty-five cases.","volume":"116","author":"Way","year":"1968","journal-title":"Am J Surg"},{"key":"R459-3-20210226","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/0016-5085(95)90124-8","article-title":"Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study.","volume":"108","author":"Weber","year":"1995","journal-title":"Gastroenterology"},{"key":"R460-3-20210226","first-page":"973","article-title":"Observations on small bowel pattern associated with the Zollinger-Ellison syndrome.","volume":"82","author":"Weber","year":"1959","journal-title":"Am J Roentgenol"},{"key":"R461-3-20210226","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/00000658-196705000-00002","article-title":"Carcinoid-islet cell tumors of the duodenum.","volume":"165","author":"Weichert","year":"1967","journal-title":"Ann Surg"},{"key":"R462-3-20210226","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0002-9343(63)90212-2","article-title":"Endocrine adenomatosis and peptic ulcer in a large kindred.","volume":"35","author":"Wermer","year":"1963","journal-title":"Am J Med"},{"key":"R463-3-20210226","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0016-5085(19)32587-9","article-title":"Changes in canine gastric acid output and serum gastrin levels following massive small intestinal resection.","volume":"69","author":"Wickbom","year":"1975","journal-title":"Gastroenterology"},{"key":"R464-3-20210226","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1001\/jama.1927.02690050014007","article-title":"Carcinoma of the islands of the pancreas: hyperinsulinism and hypoglycemia.","volume":"89","author":"Wilder","year":"1927","journal-title":"JAMA"},{"key":"R465-3-20210226","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archsurg.1993.01420180085016","article-title":"Cause of death in multiple endocrine neoplasia type 1.","volume":"128","author":"Wilkinson","year":"1993","journal-title":"Arch Surg"},{"key":"R466-3-20210226","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.surg.2008.06.015","article-title":"The influence of surgery in MEN-1 syndrome: observations over 150 years.","volume":"144","author":"Wilson","year":"2008","journal-title":"Surgery"},{"key":"R467-3-20210226","first-page":"90","article-title":"An autopsy case of multiple endocrine neoplasia type 1 complicated by an ectopic ACTH producing tumor.","volume":"21","author":"Yamada","year":"2009","journal-title":"J Japan Assoc Endocr Surgeons Japanese Soc Thyroid Surg"},{"key":"R468-3-20210226","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0300-595X(80)80033-8","article-title":"Multiple endocrine neoplasia type 1.","volume":"9","author":"Yamaguchi","year":"1980","journal-title":"Clin Endocrinol Metab"},{"key":"R469-3-20210226","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mce.2006.12.032","article-title":"In search of tumor suppressing functions of menin.","volume":"265-","author":"Yang","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"R470-3-20210226","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.athoracsur.2004.07.084","article-title":"ACTH secreting thymic carcinoid associated with multiple endocrine neoplasia type 1.","volume":"81","author":"Yano","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"R471-3-20210226","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1245\/s10434-007-9566-6","article-title":"Population-based study of islet cell carcinoma.","volume":"14","author":"Yao","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R472-3-20210226","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2009.24.2669","article-title":"Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial.","volume":"28","author":"Yao","year":"2010","journal-title":"J Clin Oncol"},{"key":"R473-3-20210226","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa1009290","article-title":"Everolimus for advanced pancreatic neuroendocrine tumors.","volume":"364","author":"Yao","year":"2011","journal-title":"N Engl J Med"},{"key":"R474-3-20210226","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1507\/endocrine1927.67.7_764","article-title":"Clinical characteristics in multiple endocrine neoplasia type 1 in Japan: a review of 106 patients.","volume":"67","author":"Yoshimoto","year":"1991","journal-title":"Folia Endocrinol"},{"key":"R475-3-20210226","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.surg.2007.09.010","article-title":"Pancreatoduodenal surgery in patients with multiple endocrine neoplasia type 1: operative outcomes, long-term function, and quality of life.","volume":"142","author":"You","year":"2007","journal-title":"Surgery"},{"key":"R476-3-20210226","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1200\/JCO.1999.17.2.615","article-title":"Prospective study of the clinical course, prognostic factors and survival in patients with longstanding Zollinger-Ellison syndrome.","volume":"17","author":"Yu","year":"1999","journal-title":"J Clin Oncol"},{"key":"R477-3-20210226","first-page":"430","article-title":"Thymic carcinoid in association with MEN syndromes.","volume":"58","author":"Zeiger","year":"1992","journal-title":"Am Surg"},{"key":"R478-3-20210226","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00423-010-0712-4","article-title":"Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases.","volume":"396","author":"Zerbi","year":"2011","journal-title":"Langenbecks Arch Surg"},{"key":"R479-3-20210226","first-page":"4682","article-title":"Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas.","volume":"57","author":"Zhuang","year":"1997","journal-title":"Cancer Res"},{"key":"R480-3-20210226","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1210\/jcem-70-1-149","article-title":"Circulating fibroblast growth factor-like substance in familial multiple endocrine neoplasia type 1.","volume":"70","author":"Zimering","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"R481-3-20210226","first-page":"49","article-title":"Gastrinoma: factors influencing prognosis.","volume":"97","author":"Zollinger","year":"1985","journal-title":"Surgery"},{"key":"R482-3-20210226","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF01654904","article-title":"Thirty years experience with gastrinoma.","volume":"8","author":"Zollinger","year":"1984","journal-title":"World J Surg"},{"key":"R483-3-20210226","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/00000658-195510000-00015","article-title":"Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas.","volume":"142","author":"Zollinger","year":"1955","journal-title":"Ann Surg"},{"key":"R484-3-20210226","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00000658-197610000-00016","article-title":"Observations on the postoperative tumor growth behavior of certain islet cell tumors.","volume":"184","author":"Zollinger","year":"1976","journal-title":"Ann Surg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0b013e3182954af1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T03:23:27Z","timestamp":1715311407000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201305000-00003"}},"subtitle":["A Prospective Study Comparison of 106 MEN1\/Zollinger-Ellison Syndrome Patients With 1613 Literature MEN1 Patients With or Without Pancreatic Endocrine Tumors"],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":462,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0b013e3182954af1","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}